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Abstract
Introduction: Participant attrition is a problem common to many longitudinal studies, and when it
occurs nonrandomly, it can impact the study’s validity and generalizability. Identifying factors associated
with attrition can help to detect bias and aid in developing targeted interventions to reduce attrition.
Methods: Logistic regression and Cox proportional hazards regression models were constructed
separately for patients with rheumatoid arthritis, systemic lupus erythematosus, and other rheumatic
diseases who participated in the FORWARD study between 1998 and 2018. Results: Patient
characteristics associated with attrition included male sex, younger age, non-White race, and less
education, each of which was identified in multiple models. Score indicating poorer function or greater
disease activity on the Health Assessment Questionnaire Disability Index (HAQ), Short Form Health
Survey Mental Component Scale (MCS), and Rheumatic Disease Comorbidity Index (RDCI) were
associated with dropout in certain groups. Method of recruitment to the study was significant, though
its specific impact varied by diagnostic group and analytical technique. Discussion: Male sex and less
education as predictors of dropout concurred with previous studies, as did the relatively greater
significance of socioeconomic factors than health-related factors. The associations with poorer scores on
health indices were consistent with researchers’ logic that patients in poorer health would be more
likely to drop out. Conclusion: Patients of male sex, non-White race, younger age, and less education
and patients with poor score on health indices were more susceptible to early dropout. FORWARD is
advised to develop interventions targeted at retaining at-risk participants, such as achievement tracking
to engage younger audiences, accommodations for patients with less education, outreach to patients
who report infections, and automated communications triggered by poor scores on health indices.
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Factors Associated With Participant Attrition
in a Longitudinal, Survey-Based Rheumatic Disease Databank
Introduction
Participant attrition is a common obstacle in longitudinal research. Nonrandom attrition can
significantly damage a study’s validity and generalizability, particularly in medical research. FORWARD,
like many registries and databanks, has endeavored to limit attrition since its inception in 1998.
Recognizing factors associated with participants who drop out of a study can help to detect bias and aid
in developing targeted interventions to reduce attrition. This study aims to identify both baseline and
dynamic factors associated with attrition by use of statistical modeling.
Placement Site
FORWARD, also known as the National Databank for Rheumatic Diseases, is a large database of
patient-reported information about rheumatoid arthritis (RA), systemic lupus erythematosus (SLE),
osteoarthritis (OA), fibromyalgia, and other rheumatic diseases. For approximately 20 years, FORWARD
has been collecting data through surveys that approximately 10,000 patients complete every 6 months.
More than 50,000 patients have participated throughout the project’s history. FORWARD uses the data
to conduct its own research and makes the data available to other researchers (National Data Bank for
Rheumatic Diseases, 2017; Wolfe & Michaud, 2011).
Registries and databanks exist for many diseases and groups of diseases. Registries tend to be
single-purpose, whereas databanks may encompass multiple diseases and serve many functions (Wolfe
& Michaud, 2011). The results of research using information from registries and databanks is often
considered more generalizable than that of clinical trials because participants tend to vary more widely
than do subjects in clinical trials (Agency for Healthcare Research and Quality, 2014; Iannaccone, et al.,
2013; Krishnan, et al., 2004). Whereas subjects in a clinical trial must meet specific criteria (Friedman,
Furberg, & DeMets, 2010), generally the only condition for inclusion in a registry or databank is a
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diagnosis of the disease being studied (Agency for Healthcare Research and Quality, 2014). A further
benefit of registries and databanks is their tendency to employ long-term follow-up. This enables
collection of useful information about disease progression, which is essential in the case of rheumatic
diseases (Krishnan, et al., 2004).
FORWARD participants complete surveys online, on paper, or by phone. Patients who do not
wish to complete the 28-page comprehensive survey can opt for a 16-page version. An even shorter
questionnaire, only 2 pages long and referred to as the brief version, has also been used in the past.
Information is collected on patient demographics, medications, physical function, mental health, and
many other areas. The longer surveys contain questions that enable calculations of several health
indices developed by researchers with FORWARD and other studies.
FORWARD is one of several registries that collect longitudinal information from patients with
rheumatic diseases. Others include the Brigham and Women’s Rheumatoid Arthritis Sequential Study
(BRASS), the Arthritis, Rheumatism, and Aging Medical Information System (ARAMIS), and the National
Rheumatoid Arthritis Study (NRAS). BRASS is an ongoing study limited to patients with RA who are seen
at the Brigham and Women’s Hospital Arthritis Center. It began in 2003, has enrolled about 1,500
participants to date, and is based on information collected at annual clinic visits (Brigham & Women's
Hospital, 2018; Iannaccone, et al., 2013). ARAMIS, which was coordinated by the Stanford Arthritis
Center, began in approximately 1976 and operated until the mid-2000s. It employed the semiannual
Stanford Health Assessment Questionnaire (HAQ), which is a component of FORWARD surveys. As of the
most recent information available, ARAMIS participation numbered about 14,000, including RA patients,
OA patients, and other aging individuals (Bruce & Fries, 2005; Krishnan, et al., 2004). NRAS was operated
by the University of Connecticut and enrolled 988 patients with rheumatoid arthritis between 1988 to
1997 (Reisine, Fifield, & Winkelman, 2000).
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FORWARD has collected data for more years and on more patients than any of these databanks,
making it an unparalleled source of data on people living with rheumatic diseases. But in order to
remain so, FORWARD must continually recruit new patients and strive to retain existing patients.
The Problem of Participant Attrition
In disease registries, nonrandom participant attrition can have damaging effects both on
internal validity and on generalizability. If attrition is random – that is, the group of patients who leave
the study resembles the study cohort – then internal validity is maintained. However, if attrition is
characteristic of a subset of participants, then the remaining participants no longer resemble the
population being studied, thus degrading internal validity. This loss of validity can in turn lead to
incorrect conclusions. Medical research, compared to other areas of research, is particularly prone to
such bias because patients suffering from higher degrees of disease activity may selectively leave the
study. The result is a study sample composed primarily of patients with lower disease activity, which is
no longer generalizable to the entire patient population (Barry, 2005; Iannaccone, et al., 2013; Reisine,
Fifield, & Winkelman, 2000).
Data from BRASS, ARAMIS, and NRAS has previously been analyzed to identify characteristics of
patients who leave longitudinal studies. In each analysis, the authors compared the group of participants
who dropped out against the group of those who remained in the study. All three found that patients
who left the studies were on average less educated than those who stayed in, and men were more likely
than women to leave the study. The authors of the BRASS analysis determined that psychosocial and
socioeconomic factors had a greater impact on continued participation than did disease activity. Overall,
BRASS and ARAMIS attrition rates were 3.23% and 3.8% per cycle, respectively. NRAS reported that 54%
of patients dropped out over the course of a 9-year period, with the rate at its highest early in the study
(Iannaccone C. , et al., 2010; Iannaccone C. K., et al., 2013; Krishnan, et al., 2004; Reisine, Fifield, &
Winkelman, 2000).
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Attrition Among FORWARD Participants
FORWARD began enrolling participants in 1998 and quickly grew until 2003, the year that the
Health Information Portability and Accountability Act (HIPAA) was enacted. Prior to this time,
rheumatologists’ offices were able to provide patient information directly to FORWARD, which could
then contact patients for recruitment purposes. This conduit closed when HIPAA placed increased
privacy restrictions on patient information. Since then, FORWARD has continued to market itself to
potential participants through rheumatologists, but it must rely on the patients to initiate contact. The
active participant base decreased from 13,489 patients in 2003 to 9,047 participants in 2016, with cycleto-cycle retention rates of around 88% between 2014 and 2016 (Hanley, 2016).
Attrition among FORWARD participants has a direct detrimental effect on the research powered
by its data and an indirectly detrimental effect on public health. Research using FORWARD data drives
treatment decisions, insurance coverage, and management of the many aspects of chronic disease
(Michaud, 2016; Wolfe & Michaud, 2009). The contribution that FORWARD makes to improved
treatment and management of these diseases is invaluable, and it represents a significant public health
impact on the 54.4 million patients in the U.S. alone who suffer from RA, OA, and other rheumatic
diseases (Centers for Disease Control and Prevention, 2018).
Benefits of Understanding Factors Associated With Attrition
Among the many benefits of identifying study-specific factors associated with retention is the
detection of possible bias. Bias introduced by nonrandom attrition cannot be eliminated; however,
recognition of it can mitigate the potential for misinterpretation of results. Where possible, researchers
using the data can account for attrition bias in their analyses. When this is not feasible, they can at the
very least acknowledge it as a limitation of their findings. Identifying attrition bias, acknowledging it, and
evaluating its effect on results is thought by some to be an essential responsibility of registries and
databases (Iannaccone, et al., 2013).
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A second benefit of identifying factors associated with attrition is the opportunity to tailor
retention efforts to participants with a high risk of dropout. Baseline data can be used to do this from
the beginning of an individual’s participation. Information about dynamic factors associated with
attrition can be used to establish triggers for retention interventions later in an individual’s time with
the study.
Baseline data is collected at the beginning of a patient’s participation in the study and can
include both patient characteristics and their responses to other items on the initial survey. As discussed
above, relevant baseline characteristics that have been identified in previous attrition studies include
male sex, younger age, and less education (Iannaccone C. , et al., 2010; Iannaccone C. K., et al., 2013;
Krishnan, et al., 2004; Reisine, Fifield, & Winkelman, 2000). Identification of such characteristics enables
study administrators to effectively allocate resources and target retention efforts toward participants
who are statistically more likely to drop out.
Dynamic factors are those that change over time, such as degree of disease activity, disability
level, and employment status. When a dynamic factor is identified as being associated with attrition,
changes in a patient’s answers over time be interpreted as a warning sign. For example, a registry might
identify that participants are more likely to drop out after their survey responses indicate an increase in
work days missed due to illness. Using this information, study staff could make individual contact with
those patients to encourage continued participation and determine whether accommodations are
needed.
FORWARD can benefit from each of these aspects of attrition study results. Information about
potential attrition bias would be useful to the many researchers who utilize FORWARD data. Knowledge
of baseline characteristics associated with attrition would allow FORWARD to target interventions such
as reminder postcards to specific subgroups, allocating financial and staff resources where they will have
the greatest effect. Lastly, given information about dynamic factors associated with attrition, FORWARD
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staff could program its database system to raise an alarm when a patient’s survey responses suggest
increased risk of dropout.
Goals and Objectives
The goal of this study was to model dropout patterns using both logistic regression and survival
analysis techniques for 3 separate groups of patients. Logistic regressions utilized baseline data
modeling the log odds of dropout after less than 2 years of participation. The logistic models yielded
odds ratios that FORWARD can use to identify patients more likely to drop out early in the study. For the
survival analyses, Cox proportional hazards models were constructed using data from each patient’s last
survey along with dynamic variables representing changes in survey responses between the first and last
surveys. The outcome modeled was the mean number of phases that a patient with a given set of
characteristics remains in the study, where phases are consecutive 6-month periods. The models
produced hazard ratios that FORWARD can use to identify individuals at a risk of earlier dropout than
others. Logistic regression and survival models were constructed separately for RA patients, SLE
patients, and patients with other rheumatic diseases.
The significance of this attrition study is not limited to FORWARD but extends as well to other
rheumatic disease databanks and the general scientific community. This analysis is the first such study
utilizing a rheumatic disease database of its size, longevity, and breadth of focus. Previous analyses of
attrition trends in rheumatic disease registries and databases were based on smaller samples, a more
narrowly defined study population, a shorter study period, or a combination of these limitations.
Further, this analysis can serve as a model for any longitudinal study seeking to gain awareness of the
factors associated with its own attrition patterns.
Ethics
Approval for this study was sought from the University of Nebraska Medical Center Institutional
Review Board, which determined that the research being undertaken was not subject to its oversight.
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The existing data will be de-identified by FORWARD prior to my receipt of it, allaying privacy and
confidentiality concerns. There are no safety concerns. The researcher has no conflicts of interest.
Methods
This study has 2 aims:
1) Develop logistic regression models to identify baseline factors associated with dropout at
less than 2 years of participation and report odds ratios for those factors.
2) Develop Cox proportional hazards models to identify factors associated with time to
dropout and report hazard ratios for those factors.
Study Design
This study was a retrospective, secondary analysis of existing data.
Data Source
FORWARD provided deidentified data in SAS Xport Transport File format. Data was extracted
from each patient’s enrollment record, first survey, and last survey. In order to scale this study to a size
manageable within the scope of a master’s capstone, only a preselected subset of data elements in
FORWARD records was provided. These data elements were selected by the researcher and by
FORWARD co-director Kaleb Michaud. Consideration was given to the findings of previous studies, items
believed to be clinically relevant, and information that would be useful to FORWARD’s recruitment and
retention strategies. All available data through June 2018 were analyzed.
Eligibility Criteria and Diagnosis Groups
Inclusion criteria follow:
1) confirmed eligibility for participation in FORWARD;
2) completion of enrollment questionnaire; and
3) completion of at least 1 comprehensive FORWARD survey, either online or on paper, after
the initial interview.

FACTORS ASSOCIATED WITH PARTICIPANT ATTRITION

16

Exclusion criteria exist for the logistic regression analyses only. Patients whose first observation
occurred in 2016 or later (phases 70 through 74, as described below) were excluded because it was not
possible for these patients to have participated for a full 2 years, guaranteeing occurrence of the
outcome of interest. No exclusion criteria exist for the survival analyses.
FORWARD’s scope includes patients with a wide variety of rheumatic diseases, and it was
expected that the factors associated with attrition might vary among diagnosis groups. FORWARD
administrators were primarily interested in models assessing dropout patterns for patients with RA and
SLE. In order to meet the organization’s needs, all analyses were performed separately on 3 groups:
1) patients with a diagnosis of RA, without SLE and with or without or other rheumatic disease
comorbidity;
2) patients with a diagnosis of SLE, with or without RA or other rheumatic disease comorbidity;
and
3) patients with other rheumatic diseases, without RA or SLE comorbidity.
Measurements
A codebook listing specific variables and their values is found in Appendix A.
Participant Characteristics. Participant characteristics that were evaluated included recruitment
method, RA diagnosis, SLE diagnosis, sex, race, education level, body mass index, and date of death.
Recruitment method and date of death were obtained from FORWARD enrollment records.
Diagnoses, sex, race, education level, and body mass index were taken from the last survey. Date of
death was used only to derive other variables and was not considered as a factor in the models. RA and
SLE diagnoses are used to assign participants to analysis groups, and RA diagnosis was considered as a
factor in the models for the SLE group.
First and Last Survey Data. The survey response data listed in this section was taken from both
the first and last surveys for each patient.

FACTORS ASSOCIATED WITH PARTICIPANT ATTRITION

17

Survey Characteristics. Data elements that characterize the survey itself were phase number,
questionnaire type, and date of completion. The phase number is an integer representing the 6-month
phase for which the survey was completed; this number was the basis for calculating each participant’s
duration of participation, as described below. An index of phases and dates is found in Appendix B.
Questionnaire type is a 4-digit code that identifies the questionnaire format, length, and other
properties, all of which were potential factors in the models.
Participant Characteristics. Participant characteristics taken from first and last surveys were
age, self-assessed health status, employment status, annual income, marital status, household size,
state of residence, and zip code. Zip code was used only to derive rural vs. urban residence and was not
considered as a factor in the models.
Indices. Many of the survey questions are used to calculate indices that are commonly used by
researchers to assess a patient’s status and degree of function. The HAQ is incorporated in full into the
longer surveys, as is another questionnaire called the Short Form Health Survey (SF-36). The survey also
includes questions for the rheumatic disease comorbidity index (RDCI), which was developed using
FORWARD and U.S. Department of Veterans Affairs data. It is a measure of health problems occurring in
conjunction with rheumatic disease, where conditions that have greater impact on rheumatic disease
patients are weighted more greatly than are others (England, Sayles, Mikuls, Johnson, & Michaud,
2015). The dataset includes numeric scores for the HAQ Disability Index, the HAQ-II, the SF-36 Physical
Component Summary (PCS), the SF-36 Mental Component Summary (MCS), and the RDCI. Scoring of of
these indices is summarized in Table 1.
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Table 1
Directionality of Health Indices
Index
Health Assessment Questionnaire Disability Index (HAQ)
Health Assessment Questionnaire II (HAQ-II)
SF-36 Physical Component Scale (PCS)
SF-36 Mental Component Scale (MCS)
Rheumatic Disease Comorbidity Index (RDCI)

Range
0–3

Direction Indicating
Poorer Health or Function
Higher

0 – 100

Lower

1–9

Higher

Note. SF-36 = Short Form Health Survey. Sources: Maska, Anderson, & Michaud, 2011; Utah Department of Health, n.d.;
England, Sayles, Mikuls, Johnson, & Michaud, 2015.

Medications. Data elements relating to the patient’s medication profile were number of
medications taken during the survey phase, number of disease-modifying antirheumatic drugs
(DMARDs), number of biologic medications, and use of opioids.
Medical Events. Data elements relating to medical events were occurrence of infection,
occurrence of myocardial infarction, presence of heart disease other than myocardial infarction,
occurrence of stroke, presence of cancer, and influenza immunization status. Each of these is based on
patients’ self-reports of experiences during the survey’s review period.
Derived Variables. Variables that were assigned or calculated were diagnosis group,
questionnaire format, questionnaire length, death phase, censoring status, duration of participation,
dropout at less than 2 years, days elapsed before survey completion, longitudinal changes in variables
assessed on first and last surveys, and degree of urbanization as defined by the Rural Health Research
Center. A detailed explanation of each of these derivations follows.
Diagnosis group was a nominal variable categorized as RA, SLE, and other rheumatic diseases.
These were determined using the RA diagnosis and SLE diagnosis variables provided by FORWARD.
Assignments were made as described above in the Diagnosis Groups section.
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Questionnaire format and questionnaire length were identified within the questionnaire type
value. Questionnaire format was categorized as web, print, and telephone. Questionnaire length was
categorized as comprehensive, short, and brief. Mapping of these values is detailed in the codebook.
Simplified marital status is a dichotomous recharacterization of the marital status variable into
single and partnered categories. Mapping of these values is detailed in the codebook.
Death phase is the survey phase corresponding to date of death. This variable was used only to
determine censoring due to death and was not considered as a factor in either model.
Censoring status assigned to participants who were known to have died in the phase
immediately following their last survey and to participants who completed phase 74, the final phase for
which data was available. Participants were not censored if they did not meet either of those criteria.
This variable was used for the survival analysis.
Duration of participation was calculated as the last survey phase minus the first survey phase.
The unit of this variable is phases, where 2 phases correspond to a period of 1 year. This variable is the
outcome in the survival analysis.
Example: 𝑃ℎ𝑎𝑠𝑒 71 [𝐽𝑢𝑙𝑦 2016] − 𝑃ℎ𝑎𝑠𝑒 56 [𝐽𝑎𝑛𝑢𝑎𝑟𝑦 2009] = 15 𝑝ℎ𝑎𝑠𝑒𝑠
Dropout at less than 2 years was coded as the event of interest when duration was less than 4
phases and non-event when duration was greater than or equal to 4 phases. This variable is used in the
logistic regression analysis.
Days elapsed is the number of days in the current phase that elapsed until the patient
completed the survey. It was calculated as the SAS date value for the date of survey completion minus
the SAS date value for the last day of the previous phase.
Example: 𝐹𝑒𝑏𝑟𝑢𝑎𝑟𝑦 6, 2014 − 𝐷𝑒𝑐𝑒𝑚𝑏𝑒𝑟 31, 2013 = 19760 − 19723 = 37
Longitudinal changes are calculated as the value for the last survey minus the value for the first
survey. This calculation is performed for HAQ, HAQ-II, PCS, MCS, RDCI, number of drugs, number of
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DMARDs, number of biologics, and health status. These data elements were created only for patients
who completed more than one survey, with missing values stored for patients who completed only a
single survey.
Degree of urbanization was determined using Rural Urban Commuting Area Codes Data (RUCA),
a project of the Rural Health Research Center. RUCA codes , which take discrete, nominal values labeled
with numbers from 1.0 to 10.6, were mapped to zip codes in FORWARD data using a table available from
the Rural Health Research Center. RUCA categories are groupings of RUCA codes specified as urban,
large rural, small rural, and isolated. Mapping of RUCA codes to RUCA categories was performed per
Rural Health Research Center definitions (WWAMI Rural Health Research Center, 2006) and is detailed
in the codebook. Only the RUCA category variable was used in analyses. RUCA codes and zip codes were
used for determining RUCA category but were not considered as factors in the models.
Some categorical variables were collapsed into fewer levels due to small cell counts or highly
uneven group sizes or for ease of interpretation, and some continuous variables were categorized to
better fit models. Recruitment method was reduced from 34 levels to 4 levels (provider referral, selfenrolled, drug registry, and other). Race was recoded as White, Black, and other. Marital status was
dichotomized to single and partnered. Health status was dichotomized to excellent/good and fair/poor.
RUCA category was dichotomized to urban and rural/isolated. Details of these recharacterizations are
specified in the codebook. Education, originally a continuous variable ranging from 0 to 17, was
categorized into 12 years or less, 13 to 16 years, and 17 years or more. Income, originally an ordinal
variable with levels ranging from $0 to $150,000, was categorized as less than $30,000, $30,000 to
$59,000, and $60,000 or more. Age, originally a continuous variable, was categorized into 4 similarly
sized groups: less than 50, 50 to 59, 60 to 69, and 70 or older.
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Preliminary Analyses
Prior to beginning statistical analysis, several data preparation steps were followed using SAS
software. The original dataset contained one observation for each patient’s first survey and a second
observation for each patient’s last survey, if more than one was completed. Static patient characteristics
were included in each observation.
Descriptive statistics were obtained for all participant characteristics and for selected additional
variables using the MEANS and FREQ procedures. The purposes of the descriptive analyses included
assessment of patient characteristics, assessment of missing data, identification of potential
interactions, and identification of predictors with insufficient heterogeneity. Histograms, box plots,
scatter plots, and other visual representations were generated for selected variables using the SGPLOT
procedure.
Logistic Regression Analyses
The purpose of the logistic regression analyses was to identify baseline factors associated with
dropping out before completing 2 years of participation. The outcome variable was Dropout. The
LOGISTIC procedure was used with the DESC option to model the probability of an event outcome.
Logistic regression analysis was performed separately on each diagnosis group.
Variables Considered as Factors. Because the logistic regression model utilized only baseline
factors, only data elements from the enrollment record and the first survey were considered for
inclusion in the model.
Predictor Variables With Missing Values or Insufficient Heterogeneity. Variables that were
shown in descriptive analyses to have excessive missing values or little heterogeneity were eliminated
prior to commencing any model building.
Simple Logistic Regression and Model Assumptions. Prior to evaluating any multiple regression
models, simple logistic regression models were constructed using each predictor variable remaining
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under consideration. The effect of a predictor was considered significant if the p-value for the parameter
estimate was less than 0.05. Odds ratios were reported for predictors that met the model assumptions
and whose effects were statistically significant.
Multiple Logistic Regression – Initial Variable Reduction. Variables with p-values less than 0.05
in simple analyses were considered for inclusion in the model. This was a reduction from the planned
threshold of 0.05 due to an excessive number of qualifying variables. Continuous variables remaining
under consideration were assessed for multicollinearity using PROC CORR. Correlations with p < 0.05
and r > 0.8 were addressed, and determination of which collinear variables to eliminate were made on a
clinical basis. Additional variables were eliminated as necessary using clinical judgment. For example, if
both HAQ score and a variable that goes into the HAQ calculation remained under consideration, one
was eliminated. If greater than 20 variables remained after these steps, additional variables were
eliminated based on clinical relevance and level of significance in simple regression models.
Multiple Logistic Regression – Full Model. All remaining variables were included in the initial
multiple logistic regression model. This model, designated as the “full model,” additionally contain up to
10 2-way interaction terms that were identified during preliminary analyses. Interactions were included
in the model only if the simple effects involved in the interaction were also present. No 3-way or higher
interaction terms were considered.
Multiple Logistic Regression – Model Selection. The final model was obtained by manual
backward selection. Significance level for variables to remain in the model was 0.05. Classes of
categorical variables were retained or dropped as a set, and simple effects were dropped only if they
were not components of any interactions remaining in the model.
Multiple Logistic Regression – Final Model. Parameter estimates, p-values, odds ratios, and 95%
confidence intervals for the odds ratios were reported for the final model.
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Survival Analyses
The purpose of the survival analyses was to identify factors associated with duration of
participation. More specifically, these analyses determined which factors have a significant effect on the
probability of continued participation as a function of time. The primary SAS procedures used were
PROC LIFETEST and PROC PHREG. Survival analysis was performed separately on each diagnosis group.
Variables Considered as Factors. The final models are intended for FORWARD administrators to
use at any point in a patient’s participation and must permit the potential for adjustments in response
to survey responses. This means that, unlike the logistic regression models, the survival models were not
limited to patient characteristics and observations from the first survey as predictors. In these models,
possible predictors included observations from the last survey, along with longitudinal changes in
measurements.
For all variables where responses to first and last surveys were provided, both observations
were considered. For variables that lent themselves well to calculation of the difference between first
and last observations, this difference was also considered as a potential predictor. In cases where at
least two forms of a survey response (first, last, and change) were viable candidates for inclusion in a
model, only one was selected. When all other factors were essentially equal, preference was generally
given to the last survey response or the longitudinal change. This selection was based on log-rank tests
of Kaplan-Meier survival estimates.
Variable Characteristics. Categorical variables, variables with insufficient heterogeneity, and
variables with many missing values were handled in the same manner as described above for logistic
regression analyses.
Kaplan-Meier Estimates. Prior to undertaking any regression analysis, a variety of Kaplan-Meier
estimate curves were constructed. The first consisted of a single plot of all data, stratified by diagnosis
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group. Additional curves were plotted to compare levels of selected variables, including both categorical
variables and categorized continuous variables, within each diagnosis group.
Initial Variable Selection. Up to 20 predictor variables were selected for consideration based on
preliminary analyses and Kaplan-Meier estimates. The list of potential factors was reduced where
necessary. Clinical relevance and findings of prior studies contributed to the list of potential factors.
Proportional Hazards Assumption. The proportional hazards assumption was assessed for each
selected predictor variable using Schoenfeld residuals and observed vs. expected plots. For observed vs.
expected plots, continuous variables were categorized into 2 or 3 levels. Failure to meet the
proportional hazards assumption was defined by a p-value less than 0.05 on the Schoenfeld residual
correlation test or blatant inconsistency between observed and expected plots. When the two tests
disagreed, further methods were employed to investigate whether the assumption was met.
Full Model. All predictors that met the proportional hazards assumption were included in the
initial Cox proportional hazards model. Up to 3 predictors that did not meet the assumption were
retained for stratification. The resulting model was designated as the “full model.”
Model Selection and Significance Threshold. The final model was obtained by manual backward
selection in the same manner as described above for logistic regression analyses. The significance level
for variables to remain in the model was 0.05.
Final Model. Parameter estimates, p-values, hazard ratios, and 95% confidence intervals for the
hazard ratios will be reported for the final model.
Assessment of Predictive Capability
Predictive capability of all models was assessed using Akaike information criterion (AIC). This
method was chosen after careful consideration of several validation methods. One possibility was
external validation by splitting the sample into a training set and a validation set; this method was
rejected with the conviction that the best estimated parameters are based on all available data, not a
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portion of it. Internal validation options included the bootstrap method and cross-validation by leaveone-out, leave-many-out, or V-fold. Bootstrap was the preferred of these. However, PROC LOGISTIC and
PROC PHREG support neither bootstrap nor cross-validation, whereas AIC can be assessed by both SAS
procedures. As AIC is an asymptotic equivalent of leave-one-out cross-validation (Shtatland, Kleinman, &
Cain, 2004), it was determined to be an acceptable alternative.
Power Analysis
Power analysis for logistic regression models (Aim 1) and survival models (Aim 2) was performed
to determine the lowest detectable odds ratios and hazard ratios. Parameters for both analyses included
90% power, 0.05 significance, and a sample size of 5,000. These power analyses were considered
conservative since the sample sizes for some diagnosis groups were expected to be larger. For the
logistic regression model, lowest detectable odds ratios for a binary predictor variable ranged from
1.023 to 1.702 given varying percentage of sample with X=1, varying response probability, and varying
correlation between predictor variables. For the survival model, lowest detectable hazard ratios ranged
from 1.003 to 1.098 given an 80% event rate, varying predictor variable standard distribution, and
varying predictor correlation. Comprehensive details of both power analyses are given in Appendix C.
Analytical Tools
Statistical analyses were performed and plots were generated using SAS/STAT® software version
9.4 for Windows. Power analysis was performed using PASS 16 Power Analysis and Sample Size
Software.
Results
Descriptive Statistics
Data was obtained on 54,027 individuals. This included 35,927 in the RA group, 2,752 in the SLE
group, and 15,349 in the other rheumatic diseases group. Table 2 gives demographic information on the
study group.
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Table 2
Participant Characteristics

Characteristic
Age, mean ± SD
Sex a
Female
Male
Race a
White
Black
Other
Education a
12 Years or Less
13 to 16 Years
17 Years or More
Marital Status a, b
Single
Partnered
Employment a
Unemployed
Paid work
Retired
Housework
Student
Disabled
RUCA Category a
Urban
Rural or Isolated
Recruitment Category
Provider Referral
Self-Enrolled
Drug Registries
Other

All Participants
(n = 54,027)
58 ± 14

RA Group
(n = 35,927)
59 ± 13

SLE Group
(n = 2,752)
50 ± 13

Other Rheumatic
Diseases Group
(n = 15,349)
59 ± 14

42,161 (80.6%)
10,149 (19.4%)

27,706 (78.9%)
7,397 (21.1%)

2,399 (93.8%)
160 (6.3%)

12,056 (82.3%)
2,592 (17.7%)

43,858 (88.6%)
2,643 (5.3%)
3,029 (6.1%)

30,020 (88.3%)
1,750 (5.2%)
2,215 (6.5%)

1,719 (73.7%)
355 (15.2%)
259 (11.1%)

12,119 (91.7%)
538 (4.1%)
555 (4.2%)

19,415 (39.6%)
21,663 (44.2%)
7,974 (16.3%)

14,408 (42.8%)
14,309 (42.5%)
4,979 (14.8%)

647 (27.9%)
1,243 (53.5%)
432 (18.6%)

4,360 (33.5%)
6,111 (46.9%)
2,563 (19.7%)

16,884 (33.4%)
33,619 (66.6%)

10,687 (32.6%)
22,138 (67.4%)

1,065 (39.4%)
1,636 (60.6%)

5,132 (34.3%)
9,845 (65.7%)

1,849 (3.8%)
18,352 (37.3%)
14,242 (28.9%)
6,296 (12.8%)
526 (1.1%)
7,983 (16.2%)

1,057 (3.3%)
11,968 (37.3%)
9,529 (29.7%)
4,145 (12.9%)
287 (0.9%)
5,103 (15.9%)

138 (5.2%)
1,067 (40.5%)
369 (14.0%)
311 (11.8%)
62 (2.4%)
687 (26.1%)

654 (4.5%)
5,317 (36.6%)
4,344 (29.9%)
1,840 (12.7%)
177 (1.2%)
2,193 (15.1%)

39,878 (74.7%)
13,525 (25.3%)

26,586 (74.9%)
8,935 (25.2%)

2,064 (75.8%)
660 (24.2%)

11,228 (74.1%)
3,930 (25.9%)

8,416 (15.6%)
13,290 (24.6%)
14,297 (26.5%)
18,024 (33.4%)

6,003 (16.7%)
6,559 (18.3%)
12,760 (35.5%)
10,605 (29.5%)

36 (1.3%)
1,094 (39.8%)
237 (8.6%)
1,385 (50.3%)

2,377 (15.5%)
5,637 (36.7%)
1,300 (8.5%)
6,034 (39.3%)

Note. All values are assessed as of the first survey. RA = rheumatoid arthritis; SLE = systemic lupus erythematosus;
RUCA = Rural Urban Commuting Area Codes.
a Data was available for all patients. Percentages are proportions of respondents for whom characteristic was known. b
Single includes never married, separated, divorced, and widowed. Partnered includes married, widowed/remarried,
divorced/remarried, and living together.

The population was comprised predominantly of White females aged in their late 40s to early
70s. Proportion of subjects who were female was approximately 80% in the RA and other rheumatic
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diseases groups and even higher at 94% in the SLE group. The combined population was 89% White, 5%
Black, and 6% of other races. The distribution by race in the RA and other rheumatic diseases group was
similar to that of the combined population; however, the SLE group was notably more diverse at 74%
White, 15% Black, and 11% of other origins. Very few participants were Asian, Pacific Islander, American
Indian, Alaskan Native, and Hispanic origin. Mean age at enrollment for the RA and other rheumatic
diseases groups was 59, with the SLE group tending lower at a median age of 50. The overall age range
of participants was 7 to 104, with the SLE group limited to 14 to 93.
Other common characteristics included urban residence, partnered status, and paid
employment or retirement. Across all groups, approximately 75% of patients who provided their
location lived in urban areas. Two-thirds of the population who provided details of marital status on
their first survey were married or living with a partner. In the RA and other rheumatic diseases groups,
approximately one-third of respondents had paid employment and one-third were retired, with 15% to
16% identifying as disabled. In the SLE group, disabled status was notably higher at 26%, a difference
that was offset primarily by a lower proportion of retired participants.
The mean education level for the combined population was about 14 years. About 40% of the
combined population reported an education level of 12 years or less, about 44% 13 to 16 years, and the
remainder 17 or more years. Distribution varied across the diagnosis groups, with the most notable
difference being a greater representation of participants with at least some college education in the SLE
group. Nearly 9% of patients who provided education information reported having less than a high
school education.
Of the 54,027 participants evaluated, more than 20% completed only a single survey. The mean
duration of participation was just 8 phases in the RA group and 7 phases in the SLE and other rheumatic
diseases group. Forty percent of the RA group dropped out after less than 2 years, along with 44% of the
SLE group and 48% of the other rheumatic diseases group. A histogram showing duration of
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participation for the combined population is shown in Figure 1. Figures showing mean duration by
selected patient characteristics are found in Appendix D.
Figure 1
Distribution of Duration of Participation Among All Patients

Certain clinical variables exhibited high rates of missing data due either to having been added to
the survey after the study had been underway for several years or to appearing only on the
comprehensive version of the survey. Household size, BMI, influenza vaccination status, and side effects
were all dropped from consideration in models due to too many missing values in all diagnosis groups.
Sufficient information on HAQ and PCS scores were available for first surveys, but they were widely
missing in last surveys. Data on MCS scores for first surveys was satisfactory for the SLE and other
rheumatic disease groups, but many values were missing in the RA group, and MCS scores for last
surveys were lacking across all groups. HAQ-II scores at both first and last observations were sufficient in
the SLE group only. Where data was sufficient for first surveys but not for last surveys, variables were
retained for logistic regression models but dropped from consideration in survival models. Where data
was sufficient in certain diagnosis groups but lacking in others, variables were carried forward on a
group-by-group basis.
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Information on comorbidities, health status, analgesic use, heart problems, infections, and
numbers of drugs, and DMARDs was sufficient for all groups on both first and last observations. Data on
biologic drugs, strokes, and cancer was suitable; however, these variables were dropped due to
insufficient heterogeneity. Questionnaire format and questionnaire length were dropped due to not all
options having been available to participants throughout the study period.
Logistic Regression Models
Odds ratios for dropout within 2 years by diagnosis group are given in Table 3. Odds ratios were
calculated from final logistic regression models that were obtained by reduction of full models
containing predictors significant in univariable models, along with selected interactions. Detailed results
of univariable and multivariable models are found in Appendices E, F, and G.
Table 3
Odds Ratios for Dropout Prior to 2 Years in Final Logistic Regression Models
OR [95% CI]
Parameter
Sex
Male vs. Female
Age (+ 10 years)
Disabled Patients
Patients Doing Housework
Patients With Paid Employment
Retired Patients
Students
Unemployed Patients
Race b
Black vs. White
Other vs. White
Marital Status
Single vs. Partnered
Education Level (+ 1 year)

RA Group

SLE Group

Other Rheumatic
Diseases Group
1.27 [1.14, 1.42]

0.89 [0.85 – 0.96]
0.85 [0.76, 0.95] a
0.88 [0.81, 0.96] a
0.84 [0.79, 0.90] a
1.11 [1.01, 1.23] a
0.74 [0.57, 0.97] a
0.83 [0.70, 0.99] a
1.40 [1.24 - 1.58]
1.47 [1.32 - 1.63]

1.31 [1.06, 1.62]
1.24 [1.01, 1.51]

0.87 [0.82 - 0.92]

0.91 [0.83, 1.00]

0.95 [0.94 – 0.96]

0.95 [0.93, 0.97]
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Table 3
Odds Ratios for Dropout Prior to 2 Years in Final Logistic Regression Models
OR [95% CI]
Parameter
Recruitment b
Provider Referral vs. Other
Self-Enrolled vs. Other
Drug Registries vs. Other
Employment b
Housework vs. Disabled
Paid Work vs. Disabled
Retired vs. Disabled
Student vs. Disabled
Unemployed vs. Disabled
Income b
$30,000 - $59,999 vs. Less Than $30,000
$60,000 or More vs. Less Than $30,000
RUCA Category
Urban vs. Rural
HAQ Score d (+ 1 unit)
Patients Assessing Health as Fair/Poor
Patients Assessing Health as Excellent/Good

MCS Score (+ 10 units)
RDCI (+ 1 unit)
Infection
(Yes vs. No)
Self-Assessed Health Status
Excellent/Good vs. Fair/Poor
Analgesic Use
Yes vs. No

RA Group

SLE Group

Other Rheumatic
Diseases Group

0.77 [0.71 - 0.83] 0.82 [0.63 – 1.05] c 1.13 [0.96, 1.33] b, c
1.02 [0.93 – 1.12] c 0.65 [0.50 - 0.86] 0.98 [0.83, 1.17] b, c
0.80 [0.74 - 0.87]
0.60 [0.42 - 0.87]
1.35 [1.10, 1.65]

0.97 [0.87 – 1.07] c 0.79 [0.58 – 1.07] c
1.15 [1.05 - 1.26]
0.70 [0.55 - 0.89]
c
1.02 [0.93 – 1.11]
0.69 [0.51 - 0.95]
1.84 [1.40 - 2.42] 0.71 [0.40 – 1.29] c
1.37 [1.17 - 1.60] 1.07 [0.72 – 1.59] c

0.95 [0.80, 1.13] a, c
0.96 [0.82, 1.12] a, c
0.82 [0.68, 1.00] a
0.86 [0.38, 1.92] a, c
1.17 [0.90, 1.52] a, c

1.00 [0.80 – 1.24] c
0.76 [0.62 - 0.94]
0.90 [0.84 - 0.95]
0.74 [0.65 - 0.85]
0.83 [0.72 – 0.97]
0.89 [0.86, 0.93]
1.06 [1.04 - 1.07]
1.12 [1.06 - 1.19]

1.19 [1.09, 1.30]

1.09 [0.98 - 1.22] c

Note. All values are assessed as of first survey. RA = rheumatoid arthritis; SLE = systemic lupus erythematosus; RUCA = Rural
Urban Commuting Area Codes; HAQ = health assessment questionnaire; MCS = mental component score; RDCI = rheumatic
disease comorbidity index.
a The model for the other rheumatic diseases group contains an interaction between age and employment. Odds ratios given for
employment categories are at age 59, the mean age for this group. b Selected pairwise odds ratios between levels of these
variables are given in Tables E4, F4, and G4. c Confidence interval is inclusive of 1. Odds ratio may be informative but should not
be considered definitive. d The model for the RA group contains an interaction term between HAQ score and self-assessed health
status. No odds ratio is given for patients in fair or poor health vs. patients in good or excellent health because the main effect of
health status was not significant.

Demographic characteristics including sex, age, race, marital status, and education level were
each significant in at least 1 diagnosis group. Males in the other rheumatic diseases group had 27%
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greater odds of dropout within 2 years than did female patients. , and non-White patients had 24% to
47% greater odds than White patients in the RA and other rheumatic diseases groups. The effect of age
was significant in the SLE and other rheumatic disease groups. In the SLE group, a 10-year age increase
corresponded to an 11% reduction in odds of dropout. In the other rheumatic diseases group, age was
dependent on employment category, older age being associated with higher dropout odds in retired
patients and lower odds in all others. Marital status was significant in the RA and other rheumatic
disease groups, with partnered patients having reduced dropout odds of 13% and 15%, respective of the
2 groups. Having 1 more year of education corresponded to a 5% reduction in dropout odds in the RA
and other rheumatic disease groups, and residing in an urban area corresponded to a 10% reduction
over rural residency in the RA group.
With regard to employment category, the greatest differences in odds were seen in the SLE
group. In this group, the odds of dropout for disabled and unemployed patients were approximately 1.5
times those for working or retired patients (odds ratios and confidence intervals given in Table F4). In
the RA group, working patients had higher odds of dropout than disabled or retired patients (OR 1.15
and 1.13, respectively). Unemployed patients had greater odds of dropout than working or retired
patients (OR 1.19 and 1.35, respectively). Income was a factor in the SLE group, where the odds of
dropout for patients in the lower income brackets (less than $30,000 and $30,000 - $59,999) were 1.34
and 1.31 times the odds for patients in the highest bracket ($60,000 or more).
The recruitment predictor had a significant overall effect on the outcome in all models. The
original recruitment variable, which had had many levels, was collapsed into 4 categories: provider
referral, self-enrolled, drug registries, and other. Although “other” was selected as the reference group
due to having the most observations, comparisons between the 3 named categories are of greater
interest. Odds ratios for these comparisons are given in Tables E4, F4, and G4. Results varied
considerably between diagnosis groups. The most notable odds ratios were as follows:
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self-enrolled vs. provider referral in the RA group: 1.33 [95% CI 1.23, 1.44];

•

self-enrolled vs. drug registry RA patients: 1.28 [95% CI 1.18, 1.39];

•

practice-enrolled vs. self-enrolled patients in the SLE group: 1.25 [95% CI 1.03, 1.52].

•

self-enrolled vs. drug registry patients in the other rheumatic diseases group: 1.28 [95% CI
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1.11, 1.48]; and
•

drug registry vs. self-enrolled patients in the other rheumatic diseases group: 1.37 [95% CI
1.18, 1.60].

Indicators of health were significant in the RA and other rheumatic disease groups. The most
noteworthy effect was that of HAQ score. In RA patients who assessed their health as excellent or good,
a 1-unit higher HAQ score (on a scale of 0 to 3) corresponded to a 17% reduction in odds of early
dropout. In RA patients patient who assessed their health as fair or poor, the reduction was 26%. In the
other rheumatic diseases group, a 10-unit higher MCS score (on a scale of 100 points) was associated
with an 11% reduction in odds. Occurrence of infection multiplied the odds by 1.12 and 1.17 in these
groups. RDCI had a slight effect in the RA group, where a 1-unit higher score (indicating more
comorbidities) corresponded to 1.06 times the odds of dropout.
Survival Models
Kaplan-Meier survival curves for each diagnosis group (Figure 2) showed clear differences in
survival probability patterns between patients with RA, patients with SLE, and patients with other
rheumatic diseases. The RA group tended toward higher survival probability than the other two groups
at all durations greater than 2 phases. The curves for the SLE and other rheumatic diseases groups were
similar up to approximately 22 phases, beyond which the other rheumatic diseases group exhibited a
notably higher survival probability for the remainder of the duration range. The log-rank test indicated
statistically significant differences in the survival functions (p < 0.001). Kaplan-Meier survival plots for a
variety of predictors within each diagnosis group are found in Appendices H, I, and J.
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Figure 2
Kaplan-Meier Survival Curves for RA, SLE, and Other Rheumatic Diseases Groups

Hazard ratios based on multivariable Cox proportional hazards regression models for each group
are shown in Table 4. As with the survival analysis, these final models were obtained by backward
selection from models containing qualifying predictors. Predictors were selected for the full models
based on log rank tests of Kaplan-Meier curves and evaluation of the proportional hazards assumption.
Among the selected predictors were a variety of patient characteristics, observations from last surveys,
and longitudinal changes from first to last surveys. Detailed results of all models are found in
Appendices H, I, and J.
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Table 4
Hazard Ratios for Final Survival Models
Parameter
Sex
Male vs. Female
Age (+ 10 years) a
Race
Black vs. White
Other vs. White
Marital Status
Single vs. Partnered
Education Level (+ 1 year)
Employment c
Housework vs. Disabled
Paid Work vs. Disabled
Retired vs. Disabled
Student vs. Disabled
Unemployed vs. Disabled
Change in RDCI (+ 1 unit difference)
Number of Drugs (+ 1 drug)
Health Status
Excellent/Good vs. Fair/Poor
Infection
Yes vs. No
Change in HAQ II Score (+ 1 unit)

RA Group
1.16 [1.12, 1.21]
0.77 [0.76, 0.78]

SLE Group

Other Rheumatic
Diseases Group

0.79 [0.75, 0.82]

1.11 [1.05, 1.18]
0.77 [0.75, 0.78]

0.96 [0.94, 0.98]

0.98 [0.97, 0.99]

1.14 [1.06, 1.23]
1.03 [0.96, 1.09] b
0.95 [0.92, 0.98]
0.96 [0.95, 0.96]
1.22 [1.15, 1.29]
1.12 [1.07, 1.18]
1.10 [1.05, 1.16]
1.25 [1.01, 1.53]
1.26 [1.15, 1.39]
0.96 [0.95, 0.97]
0.99 [0.98, 0.99]

0.99 [0.97, 1.00]
0.99 [0.98, 0.99]

1.05 [1.02, 1.08]
1.20 [1.08, 1.34]
0.85 [0.77, 0.94]

Note. All dynamic variables are assessed as of the last survey. RA = rheumatoid arthritis; SLE = systemic lupus erythematosus;
RDCI = rheumatic disease comorbidity index.
a Odds ratio for a 1-year age increase in both the RA group and the other rheumatic diseases group was 0.97 [0.97 – 0.98].
Odds ratio for 1-year increase in the SLE group was 0.98 [0.97 – 0.98]. b Confidence interval is inclusive of 1. Odds ratio may be
informative but should not be considered definitive. c Pairwise odds ratios for selected employment types are given in Table
H4.

The most noteworthy predictor in all models was age, with a 10-year age increase
corresponding to a 21% to 23% reduction in hazard of dropout. Sex was also an important predictor with
hazard ratios for males vs. females of 1.16 in the RA group and 1.11 in the other rheumatic diseases
group. Race was significant only for the comparison between Black and White patients in the RA group,
where the hazard for Black patients was 1.14 times that of White patients.
Employment was significant in the RA models, where paid work, housework, retirement, and
unemployment were all associated with higher hazards than that of disabled status. Hazard ratios for
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several pairwise comparisons among employment categories are presented in Table G4. The most
notable were unemployed patients and patients whose primary occupation was housework at 1.26 and
1.22 times, respectively, the hazard of disabled patients. The hazard ratio for paid work vs. disabled was
1.12, and the ratio for retired vs. disabled was 1.10.
Marital status was significant in the RA group, as was education in all groups, with partnered
status and more education having slightly lower hazards.
Among predictors describing patients’ health, the most notable effects were occurrence of
infection and change in HAQ II Score among SLE patients. Infection increased the hazard of dropout over
time by a factor of 1.20. A larger positive change in the HAQ II score was associated with a lower hazard
of dropout; reversing the numbers gives an odds ratio of 1.18 for each additional unit lower that the
HAQ II score dropped between the first and last surveys. Number of drugs and change in RDCI had smallscale effects in the RA and other rheumatic diseases groups, with a higher number of drugs and
worsening comorbidity corresponding to a lower dropout hazard over time. Additionally, excellent or
good health carried 1.05 times the hazard of fair or poor health in the RA group.
Discussion/Recommendations
Based on previous research using BRASS, ARAMIS, and NRAS data, expectations prior to this
analysis were that male patients and those with less education would be at greater risk of dropout. Both
effects were confirmed. The final models demonstrated that male patients in the other rheumatic
diseases group had higher odds of dropout within 2 years, and males in both the RA and other
rheumatic diseases groups had higher hazard of dropout over time. Although sex was not retained a
predictor in the other multivariable models, simple logistic regression and Kaplan-Meier survival plots
indicated that males tended toward greater rates of dropout in all groups. Education level was a
predictor in all final models except the logistic regression for the SLE group, and in each case less
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education was associated with higher odds or hazard of dropout. The full logistic regression model for
the SLE group did contain education, and the result was the same.
In accordance with Iannaccone’s findings in the BRASS study (2013), socioeconomic factors in
general were expected to be relevant to dropout patterns. This held true, with the logistic regression
models for the RA and other rheumatic diseases groups revealing non-White patients to have 24 to 47%
greater odds of dropout within 2 years than White patients. This finding was consistent in the survival
model for the same group, though on a smaller scale. Univariable logistic regression for the other
rheumatic diseases group indicated that Black patients had 38% greater odds of dropout than White
patients, and patients of other races had 33% greater odds than White patients. Marital status was
significant in some models, in each case indicating that single patients were more likely to drop out.
In the area of disease and health characteristics, FORWARD administrators expected that
greater disease activity, as indicated by scores on functional indices, would be associated with dropout.
Further, it was anticipated that worsening scores would precipitate dropout. This was confirmed in the
logistic regression model for the RA group, where lower HAQ score and higher RDCI carried greater odds
of dropout. Change in HAQ II score was a predictor in the survival model for the SLE group, where a
greater mean decrease in score between first and last surveys was associated with greater hazard of
dropout. Occurrence of infection was associated with greater risk of dropout in the models in which it
appeared, as was also expected.
In general, worse health index scores were an indicator of greater risk of dropout across models.
Further analysis is warranted to determine specific thresholds associated with concerning increases in
risk. This information would be valuable to FORWARD administrators, who could implement
interventions based on specific values.
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Impact of Findings
Given the awareness of these factors associated with attrition, FORWARD is empowered to
critically evaluate its approaches to retention efforts with a focus on the patients most at risk for early
dropout. Just a few of the many opportunities follow:
•

development of programs that are likely to be effective with men and younger patients;

•

assessment of existing communications and the participant survey itself to ensure that
patients with less education are being adequately accommodated;

•

allocation of funds to recruitment efforts that result in a more retainable patient base;

•

implementation of automated alerts that trigger when a patient’s HAQ score declines or
RDCI rises or when a patient reports having had an infection in the most recent survey
phase.

Beyond FORWARD, other databanks and registries with similar structure might apply the
analytical techniques used here to their own data. Knowledge of study-specific factors associated with
participant attrition could enable administrators of these studies to improve their own retention
programs.
Limitations and Opportunities for Further Research
This study has several limitations, chief among them the narrow selection of data elements from
among the many available in FORWARD data, which was necessitated by the scope of this project.
Factors may exist that possess greater predictive ability than those considered, whether currently in
FORWARD records or in questions not yet asked of patients. Additionally, meaningful interactions may
be present that were not tested in models, particularly in the survival models where interactions were
not considered. Further regarding statistical procedures, the models presented here did not provide for
the use of repeated measures data. Assessment of a dataset containing the full series of each patient’s
survey responses might reveal patterns beyond those detectable by this limited analysis. Expanding the
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outcome to account for competing risks, such as the various reasons given for dropout in exit interviews,
might also be informative. Added value might also be identified by reducing the other rheumatic
diseases group to specific diagnosis groups or by isolating the group of crossover patients with both RA
and SLE diagnoses..
Conclusions
The results of this study suggest that patients of non-White race, younger age, and less
education are more susceptible to early dropout from FORWARD participation. Clinical factors may also
play a part, though their role seems less straightforward. Nevertheless, knowledge of these clinical
factors as well as the socioeconomic ones can enable FORWARD to prioritize retention efforts that are
tailored toward patients at greater risk of dropout.
FORWARD administrators are advised to take the following actions:
•

Pursue the existing proposal for creating an achievement tracking system analogous to
those found in video games. This should be featured in a mobile application rather than on
the organization’s web site. Such a system would likely fare well with younger patients,
particularly males.

•

Investigate the reasons for patients with less education dropping out of the study at greater
rates. Identify other characteristics that are associated with less education and with
dropout, then review existing programs with these in mind. Conduct a root cause analysis to
seek out the ultimate causes of dropout. If patients with lower education are intimidated by
the comprehensive survey, consider inviting them to instead use the short survey or to
participate by phone. Consider similar solutions if socioeconomic factors such as shift work,
non-partnered status, or larger households leave the participants little time to complete
surveys.
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Assess the motivations of self-enrolled patients, who tend toward greater risk of dropout.
Find out why they enrolled in FORWARD, what their expectations were, and how the study
met or did not meet those expectations. Use this information to design interventions
appropriate to those findings, and target such programs to self-enrolled patients.

•

Expand on the actions taken by FORWARD staff when patients report infections. When staff
contact patients to obtain details of the infections, have them also ask whether
accommodations are needed for the following survey. If patients fail to participate in the
following phase, employ a simple targeted intervention such as a phone call or a letter
wishing them well after their illness and encouraging them to resume participation with the
next phase.

•

Revisit the data on health index scores and dropout. Identify the HAQ, MCS, and RDCI
thresholds that correspond to notable increases in risk, considering that different thresholds
may apply to patients with different characteristics. Develop a simple SQL query to identify
respondents whose scores are below the determined thresholds, outputting a mailing list
for the selected patients. Craft a simple message that encourages continued participation to
be sent by e-mail or letter. Automate this process to run monthly against surveys received
since the previous run.

FACTORS ASSOCIATED WITH PARTICIPANT ATTRITION

40

References
Agency for Healthcare Research and Quality. (2014). Registry design. In R. E. Gliklich, N. A. Dreyer, & M.
B. Leavy (Eds.), Registries for evaluating patient outcomes: A user's guide (3 ed.). Agency for
Healthcare Research and Quality. Retrieved from
https://www.ncbi.nlm.nih.gov/books/NBK208632/
Arthritis Foundation. (n.d.). Arthritis by the numbers: Book of trusted facts & figures. Atlanta: Arthritis
Foundation. Retrieved March 20, 2017, from
http://www.arthritis.org/Documents/Sections/About-Arthritis/arthritis-facts-stats-figures.pdf
Barry, A. E. (2005). How attrition impacts the internal and external validity of longitudinal research.
Journal of School Health, 75(7).
Brigham & Women's Hospital. (2018). About BRASS. Retrieved September 24, 2018, from BRASS:
http://www.brassstudy.org/brass-information/overview/
Bruce, B., & Fries, J. F. (2005). The Arthritis, Rheumatism and Aging Medical Information System
(ARAMIS) - Still young at 30 years. Clinical and Experimental Rheumatology, 23(5), S-163-S-167.
Centers for Disease Control and Prevention. (2015, October 28). Cost statistics | data and statistics |
arthritis | CDC. Retrieved March 20, 2017, from Centers for Disease Control and Prevention:
https://www.cdc.gov/arthritis/data_statistics/cost.htm
Centers for Disease Control and Prevention. (2018, July 18). National statistics | data and statistics |
arthritis | CDC. Retrieved September 24, 2018, from Centers for Disease Control and Prevention:
https://www.cdc.gov/arthritis/data_statistics/national-statistics.html
England, B. R., Sayles, H., Mikuls, T. R., Johnson, D., & Michaud, K. (2015, May). Validation of the
rheumatic disease comorbidity index. Arthritis Care & Research, 67(6), 865-872.
Friedman, L. M., Furberg, C. D., & DeMets, D. L. (2010). Study population. In L. M. Friedman, C. D.
Furberg, & D. L. DeMets, Fundamentals of clinical trials (4 ed.). New York: Springer.

FACTORS ASSOCIATED WITH PARTICIPANT ATTRITION

41

Gabriel, S. E., Crowson, C. S., Campion, M. E., & O'Fallon, W. M. (1997). Indirect and nonmedical costs
among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.
The Journal of Rheumatology, 24(1), 43-48.
Hanley, J. (2016). National data bank for rheumatic diseases: Recruitment and retention study.
University of Nebraska Omaha. Retrieved from Unpublished report
Iannaccone, C. K., Fossel, A., Tsao, H., Cui, J., Weinblatt, M., & Shadick, N. (2013). Factors associated with
attrition in a longitudinal rheumatoid arthritis registry. Arthritis Care & Research, 1183-1189.
doi:10.1002/acr.21940
Iannaccone, C., Fossel, A., Tsao, H., Cui, J., Weinblatt, M., & Shadick, N. (2010). Factors associated with
attrition in a longitudinal rheumatoid arthritis registry [research poster]. Retrieved from
https://www.brassstudy.org/wp-content/uploads/2010/08/Factors-of-Attrition-in-alongitiudinal-RA-registry1.pdf
Krishnan, E., Murtagh, K., Bruce, B., Cline, D., Singh, G., & Fries, J. F. (2004). Attrition bias in rheumatoid
arthritis databanks: A case study of 6346 patients in 11 databanks and 65,649 administrations of
the Health Assessment Questionnaire. The Journal of Rheumatology, 31(7), 1320-1326.
Michaud, K. (2016, January). Notes from the directors: A story about being heard. The NDB Research
Newsletter. Retrieved March 21, 2017, from https://www.arthritisresearch.org/sites/default/files/NDB%20Jan%202016.pdf
Myaasoedova, E., Crawson, C. S., Kremers, H. M., Therneau, T. M., & Gabriel, S. E. (2010). Is the
incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007.
Arthritis & Rheumatology, 62(6), 1576-1582. doi:10.1002/art.27425
National Data Bank for Rheumatic Diseases. (2017). About the NDB. Retrieved March 21, 2017, from
National Data Bank for Rheumatic Diseases: https://www.arthritis-research.org/about/aboutndb

FACTORS ASSOCIATED WITH PARTICIPANT ATTRITION

42

Reisine, S., Fifield, J., & Winkelman, D. K. (2000). Characteristics of rheumatoid arthritis patients: Who
participates in long‐term research and who drops out? Arthritis Care & Research, 13(1), 3-10.
Schappert, S. M., & Rechtsteiner, E. A. (2011). Ambulatory medical care utilization estimates for 2007.
National Center for Health Statistics.
Shtatland, E. S., Kleinman, K., & Cain, E. M. (2004). A new strategy of model building in PROC LOGISTIC
with automatic variable selection, validation, shrinkage and model averaging. Cary, NC: SAS
Institute Inc.
Utah Department of Health. (n.d.). Interpreting the SF-12: Comparing versions 1 and 2 of the SF-12.
Retrieved December1 2018, from
http://health.utah.gov/opha/publications/2001hss/sf12/SF12_Interpreting.pdf
Wolfe, F., & Michaud, K. (2009). Predicting depression in rheumatoid arthritis: The signal importance of
pain extent and fatigue, and comorbidity. Arthritis Care & Research, 61(5), 667-673.
Wolfe, F., & Michaud, K. (2011). The National Data Bank for Rheumatic Diseases: a multi-registry
rheumatic disease data bank. Rheumatology, 50(1). doi:10.1093/rheumatology/keq155
WWAMI Rural Health Research Center. (2006). Rural Urban Commuting Area Codes Data. Retrieved
November 27, 2018, from WWAMI Rural Health Research Center:
http://depts.washington.edu/uwruca/ruca-approx.php

FACTORS ASSOCIATED WITH PARTICIPANT ATTRITION

43

Acknowledgements
My achievements in this project were greatly aided by the following people:
•

my capstone committee – Dr. Jane Meza, Dr. Lorena Baccaglini, and Dr. Kaleb Michaud;

•

Rebecca Schumacher of FORWARD and Harlan Sayles of the UNMC College of Public Health
and FORWARD for their assistance with data issues;

•

Dr. Christopher Wichman and Dr. Gleb Haynatzki for lengthy conversations about analytical
methods early in the process;

•

my friends and colleagues Marcela Carvajal Suarez and Leah Swanson for giving me a
glimpse of their own capstone processes so I had an idea of what to expect;

•

my sister, Kristyn Clapp, for literally being my right hand when I realized at the last minute
that my presentation needed reformatting beyond what I could handle with a broken
thumb;

•

my sister, Karolyn Grafel, for listening to all my woes along the way; and

•

my parents, Kent Grafel and Mary Haller, for all the times they told me they were proud of
me.

FACTORS ASSOCIATED WITH PARTICIPANT ATTRITION

44

Appendix A – Codebook
Variable:

NDB Patient Key

Type:

Num

SAS Name:

PATKEY

Format:

16.0

Variable:

Survey Identifier

Type:

Num

SAS Name:

SURVEY

Format:

???

Value

Label

1

First

2

Last

Variable:

Number of Observations

Type:

Num

SAS Name:

NumObs

Format:

???

Notes:

Number of observations in dataset for corresponding NDB Patient Key.
Range is 1-2. A value of 1 indicates that the patient completed only a
single survey. A value of 2 indicates that the patient completed more than
1 survey, and the dataset contains observations from the patient’s first
and last surveys.

Variable:

RA

Type:

Num

SAS Name:

RA

Format:

YNFMT

Value

Label

0

No

1

Yes
Notes:

Diagnosis of rheumatoid arthritis.
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Variable:

SLE

Type:

Num

SAS Name:

SLE

Format:

YNFMT

Value

Label

0

No

1

Yes
Notes:

Diagnosis of systemic lupus erythematosus.

Variable:

Recruitment Method

Type:

Num (8)

SAS Name:

Recruit

Format:

RECRUITFMT

Value

Label

Value

Label

1

Arava

22

ARCK

2

30 Day NDB

23

UNMC/RAIN

3

Practices

24

Luggen

4

Wichita Databank

25

Bergman

6

Self Referral

26

MD Enroll 2008

7

FOCUS

27

BMS Website RALLY

8

Remicade-new start

28

Individual Site Enrollment

9

Remicade-old users

29

Cimzia Registry

10

Centocor Report Project

30

Edgerton

13

30day NoHAQ

31

AIRS

14

30day HAQ 2003

32

Walter Reed

16

International Website/Community

33

Soforo

17

Lupus-Community Project

34

FDR

18

HERO Followup study

35

UCSF RA Panel

19

Lupus-Harley/Oklahoma

37

UCSF Lupus

20

Katz Diagnosis Evaluation

38

International Dupuytren Data Bank

21

RALLY

39

UAB VERVE Study
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Variable:

Simplified Recruitment Method

Type:

Num

SAS Name:

RECRUITSIMP

Format:

RECRUITSIMPFMT

Value

Label

Value

Label

1

Provider Referral

3

Drug Registries

2

Self-Enrolled

4

Other

Notes:

Recategorization of RECRUIT into broader categories.
RECRUITSIMP = 1 when RECRUIT is 2, 3, 4, 17, 19, 22, 23, 24, 25, 26, 28,
30, 32, or 33.
RECRUITSIMP = 2 when RECRUIT is 6, 16, or 31.
RECRUITSIMP = 3 when RECRUIT is 1, 8, 9, 10, 27, or 29.
RECRUITSIMP = 4 when RECRUIT is any other value in the dataset.

Variable:

Date of Death

Type:

Num

SAS Name:

DEATHDAT

Format:

MMDDYY10

Notes:

SAS date value for date of death.

Variable:

Questionnaire Type

Type:

Num (8)

SAS Name:

QTYPE

Format:

QTYPEFMT

Value

Label

Value

Label

10

CSQ-Comprehensive paper

1010

RAFib Paper

11

CSQ-Comprehensive telequest

1011

RAFib TQ

12

CSQ-Comprehensive Web

1012

RAFib Web

20

SSQ-Short paper

2010

OA Paper

21

SSQ-Short telequest

2011

OA TQ

22

SSQ-Short Web

2012

OA Web

30

BSQ-Brief paper

3010

Lupus Paper

31

BSQ-Brief telequest

3011

Lupus TQ

32

BSQ-Brief Web

3012

Lupus Web

512

Int l English-Comprehensive Web

4010

Gout Paper

730

Remicade-Brief paper

4012

Gout Web

731

Remicade-Brief telequest

6010

SpA Paper

810

Spanish-Comprehensive paper

6011

SpA Telequest

812

Spanish-Comprehensive Web
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Variable:

Education Level in Years

Type:

Num (8)

SAS Name:

EDLEVEL

Format:

BEST

Variable:

Education Category

Type:

Num (8)

SAS Name:

EDCAT

Format:

EDCATFMT

Value

Label

Value

Label

1

12 Years or Less

3

17 Years or More

2

13 – 16 Years

Variable:

Race

Type:

Num (8)

SAS Name:

ETHORIG

Format:

ETHFMT

Value

Label

Value

Label

1

White, not of Hispanic origin

5

Hispanic

2

Black, not of Hispanic origin

6

Puerto Rican

3

Asian or Pacific Islander

7

Other

4

American Indian or Alaskan Native

Variable:

Simplified Race

Type:

Num (8)

SAS Name:

ETHSIMP

Format:

ETHSIMPFMT

Value

Label

Value

Label

1

White, not of Hispanic origin

3

Other

2

Black, not of Hispanic origin

Variable:

Sex of Patient

Type:

Num (8)

SAS Name:

SEX

Format:

SEXFMT

Value

Label

0

Female

1

Male
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Variable:

Age of Patient

Type:

Num (8)

SAS Name:

AGE1 & AGE2

Format:

BEST

Variable:

Age Category

Type:

Num (8)

SAS Name:

AGECAT1 & AGECAT2

Format:

AGE4FMT

Value

Label

Value

Label

1

< 50

3

60 – 69

2

50 – 59

4

≥ 70

Variable:

Marital Status by Code

Type:

Num (8)

SAS Name:

MARITAL1 & MARITAL2

Format:

MARITALFMT

Value

Label

Value

Label

1

Never married

5

Widowed

2

Married

6

Widowed/remarried

3

Separated

7

Divorced/remarried

4

Divorced

8

Living together

Variable:

Simplified Marital Status

Type:

Num (8)

SAS Name:

MARSIMP1 & MARSIMP2

Format:

MARSIMPFMT

Value

Label

1

Single

2

Partnered
Notes:

Dichotomous recategorization of marital status.
MARSIMP = 1 when MARITAL = 1, 3, 4, or 5.
MARSIMP = 2 when MARITAL = 2, 6, 7, OR 8.
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Variable:

Total Annual Income

Type:

Num (8)

SAS Name:

INCOME1 & INCOME2

Format:

BEST

Value

Label

Value

Label

1

$0 - $9,999

7

$60,000 - $69,999

2

$10,000 - $19,999

8

$70,000 - $79,999

3

$20,000 - $29,999

9

$80,000 - $89,999

4

$30,000 - $39,999

10

$90,000 - $99,999

5

$40,000 - $49,999

11

$100,000 - $149,999

6

$50,000 - $59,999

12

$150,000 or More

Variable:

Categorized Annual Income

Type:

Num (8)

SAS Name:

INCOMECAT1 & INCOMECAT2

Format:

INCOMECATFMT

Value

Label

Value

Label

1

Less Than $30,000

3

$60,000 or More

2

$30,000 - $59,999
Notes:

Recategorization of INCOME1 & INCOME2 variables.

Variable:

Body Mass Index

Type:

Num (8)

SAS Name:

BMI

Format:

BEST

Notes:

Measured in kg/m2.

Variable:

HAQ Disability Score

Type:

Num (8)

SAS Name:

HAQ1 & HAQ2

Format:

BEST

Notes:

Range 0-3. Higher score indicates greater disability.

Variable:

HAQ II Score

Type:

Num (8)

SAS Name:

HAQII1 & HAQII2

Format:

BEST

Notes:

Range 0-3. Higher score indicates greater disability.
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Variable:

SF36 Physical Component Scale

Type:

Num (8)

SAS Name:

PCS1 & PCS2

Format:

BEST

Notes:

Range 0-100. Lower score indicates lower level of health.

Variable:

SF36 Mental Component Scale

Type:

Num (8)

SAS Name:

MCS1 & MCS2

Format:

BEST

Notes:

Range 0-100. Lower score indicates lower level of health.

Variable:

Rheumatic Disease Comorbidity
Index (RDCI)

Type:

Num (8)

SAS Name:

COMOR1 & COMOR2

Format:

BEST

Variable:

Self-Assessed Health Status

Type:

Num (8)

SAS Name:

HEALTH1 & HEALTH2

Format:

BEST

Value

Label

Value

Label

1

Excellent

3

Fair

2

Good

4

Poor

Variable:

Simplified Health Status

Type:

Num (8)

SAS Name:

HEALTHSIMP1 & HEALTHSIMP2

Format:

HEALTHSIMPFMT

Value

Label

1

Excellent/Good

2

Fair/Poor
Notes:

Value

Label

Dichotomous recategorization of Self-Assessed Health Status.
HEALTHSIMP is 1 when HEALTH is 1 or 2.
HEALTHSIMP is 2 when HEALTH is 3 or 4.
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Variable:

Phase Number

Type:

Num (8)

SAS Name:

PHASE1 & PHASE2

Format:

PHASEFMT

Notes:

Custom format is a text version of numeric value where 35 = ‘Phase 35’.
Mapping of dates to phases is found in Appendix B.

Variable:

Number of Drugs

Type:

Num (8)

SAS Name:

DRUGS1 & DRUGS2

Format:

BEST

Variable:

Number of DMARDs

Type:

Num (8)

SAS Name:

DMARDS1 & DMARDS2

Format:

BEST

Notes:

DMARDs are disease-modifying anti-rheumatic drugs.

Variable:

Number of Biologics

Type:

Num (8)

SAS Name:

BIOLCNT1 & BIOLCNT2

Format:

BEST

Variable:

Analgesic Use

Type:

Num (8)

SAS Name:

ANALG1 & ANALG2

Format:

YNFMT

Notes:

Includes acetaminophen products as well as opioids.

Variable:

Have CVA Problem Now

Type:

Num (8)

SAS Name:

STROKE1 & STROKE2

Format:

YNFMT

Value

Label

0

No

1

Yes
Notes:

Occurrence of stroke in past 6 months.
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Variable:

Have CVO Problem Now

Type:

Num (8)

SAS Name:

HEART1 & HEART2

Format:

YNFMT

Value

Label

0

No

1

Yes
Notes:

Existence of heart condition other than heart attack in last 6 months.

Variable:

Employment Status

Type:

Num (8)

SAS Name:

EMPLOY1 & EMPLOY2

Format:

EMPFMT

Value

Label

Value

Label

0

Unemployed

4

Student

1

Paid work

5

Disabled

2

Retired

6

Working Part time

3

Housework

7

Other

Variable:

Have MI Problem Now

Type:

Num (8)

SAS Name:

MI1 & MI2

Format:

YNFMT

Value

Label

0

No

1

Yes
Notes:

Occurrence of heart attack in last 6 months (survey page 3).

Variable:

Cancer Problem Now

Type:

Num (8)

SAS Name:

CANCER1 & CANCER2

Format:

YNFMT

Value

Label

0

No

1

Yes
Notes:

Presence of cancer during last 6 months (survey page 3).
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Variable:

Number of People Living in
Household

Type:

Num (8)

SAS Name:

HOUSEHOLD1 & HOUSEHOLD2

Format:

BEST

Variable:

Flu Immunization in Current Phase

Type:

Num (8)

SAS Name:

FLU1 & FLU2

Format:

YNFMT

Notes:

Value

Label

0

No

1

Yes

Variable:

Ever Had Side Effect to Arthritis
Medication

Type:

Num (8)

SAS Name:

SE1 & SE2

Format:

YNFMT

Value

Label

0

No

1

Yes

Variable:

Infections in Current Phase

Type:

Num (8)

SAS Name:

INFXN1 & INFXN2

Format:

YNFMT

Value

Label

0

No

1

Yes

Variable:

Zip Code (character)

Type:

Char (12)

SAS Name:

ZIP

Format:

N/A

Variable:

Zip Code (numeric)

Type:

Numeric

SAS Name:

ZIPN

Format:

5.0
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Variable:

Diagnosis Group

Type:

Num (8)

SAS Name:

DX

Format:

DXFMT

Value

Label

Value

Label

1

RA

3

Other rheumatic diseases

2

SLE
Notes:

DX = 1 when RA = 1. DX = 2 when SLE = 1. DX -3 when RA = 0 and SLE = 0.

Variable:

Questionnaire Format

Type:

Num (8)

SAS Name:

QFORMAT1 & QFORMAT2

Format:

QFORMATFMT

Value

Label

Value

Label

1

Web

3

Telephone

2

Paper
Notes:

QFORMAT = 1 when QTYPE = 12, 22, 32, 512, 812, 1012, 2012, 3012, or
412.
QFORMAT = 2 when QTYPE = 10, 20, 30, 730, 810, 1010, 2010, 3010,
4010, or 6010.
QFORMAT = 3 when QTYPE = 11, 21, 31, 731, 1011, 2011, 3011 or 6011.

Variable:

Questionnaire Length

Type:

Num (8)

SAS Name:

QLEN1 & QLEN2

Format:

QLENFMT

Value

Label

Value

Label

1

Comprehensive

3

Brief

2

Short
Notes:

QLEN = 1 when QTYPE = 10, 11, 12, 512, 810, 812, 1010, 1011, 1012,
2010, 2011, 2012, 3010, 3011, 3012, 4010, 4012, 6010, or 6011.
QLEN = 2 when QTYPE = 20, 21, or 22.
QLEN = 3 when QTYPE = 30, 31, 32, 730, or 731.
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Variable:

Death Phase

Type:

Num (8)

SAS Name:

DEATHPHASE

Format:

PHASEFMT

Notes:

Phase during which DEATHDAT occurs. Mapped according to schedule of
phases in Appendix B.

Variable:

Censoring Status

Type:

Num (8)

SAS Name:

CENSOR

Format:

CENSORFMT

Value

Label

0

Censored

1

Not Censored
Notes:

CENSOR = 0 when DEATHPH = PHASE2 + 1.
CENSOR = 0 when PHASE2 = 39.
CENSOR = 1 if neither condition is met.

Variable:

Duration of Participation

Type:

Num (8)

SAS Name:

DURATION

Format:

BEST

Notes:

Calculated as: 𝐷𝑈𝑅𝐴𝑇𝐼𝑂𝑁 = 𝑃𝐻𝐴𝑆𝐸2 − 𝑃𝐻𝐴𝑆𝐸1

Variable:

Dropout at Less than 2 Years

Type:

Num (8)

SAS Name:

DROPOUT

Format:

YNFMT

Value

Label

0

No

1

Yes
Notes:

DROPOUT = 0 when DURATION ≥ 4.
DROPOUT = 1 when DURATION < 4.

Variable:

Change in HAQ Disability Score

Type:

Num (8)

SAS Name:

HAQCHG

Format:

BEST

Notes:

Calculated as: 𝐻𝐴𝑄𝐶𝐻𝐺 = 𝐻𝐴𝑄2 − 𝐻𝐴𝑄1
Range: -3 to +3.
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Variable:

Change in HAQ II Score

Type:

Num (8)

SAS Name:

HAQIICHG

Format:

BEST

Notes:

Calculated as: 𝐻𝐴𝑄𝐼𝐼𝐶𝐻𝐺 = 𝐻𝐴𝑄𝐼𝐼2 − 𝐻𝐴𝑄𝐼𝐼1
Range: -3 to +3.

Variable:

Change in SF36 Physical
Component Scale

Type:

Num (8)

SAS Name:

PCSCHG

Format:

BEST

Notes:

Calculated as: 𝑃𝐶𝑆𝐶𝐻𝐺 = 𝑃𝐶𝑆2 − 𝑃𝐶𝑆1
Range: -100 to +100.

Variable:

Change in SF36 Mental Component
Scale

Type:

Num (8)

SAS Name:

MCSCHG

Format:

BEST

Notes:

Calculated as: 𝑀𝐶𝑆𝐶𝐻𝐺 = 𝑀𝐶𝑆2 − 𝑀𝐶𝑆1
Range: -100 to +100.

Variable:

Change in RDCI

Type:

Num (8)

SAS Name:

COMORCH

Format:

BEST

Notes:

Calculated as: 𝐶𝑂𝑀𝑂𝑅𝐶𝐻𝐺 = 𝐶𝑂𝑀𝑂𝑅2 − 𝐶𝑂𝑀𝑂𝑅1
Range: -9 to +9.

Variable:

Change in Number of Drugs

Type:

Num (8)

SAS Name:

DRUGCHG

Format:

BEST

Notes:

Calculated as: 𝐷𝑅𝑈𝐺𝐶𝐻𝐺 = 𝐷𝑅𝑈𝐺𝑆2 − 𝐷𝑅𝑈𝐺𝑆1

Variable:

Change in Number of DMARDs

Type:

Num (8)

SAS Name:

DMARDCHG

Format:

BEST

Notes:

Calculated as: 𝐷𝑀𝐴𝑅𝐷𝐶𝐻𝐺 = 𝐷𝑀𝐴𝑅𝐷𝑆2 − 𝐷𝑀𝐴𝑅𝐷𝑆1
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Variable:

Change in Number of Biologic
Drugs

Type:

Num (8)

SAS Name:

BIOLCHG

Format:

BEST

Notes:

Calculated as: 𝐵𝐼𝑂𝐿𝐶𝐻𝐺 = 𝐵𝐼𝑂𝐿𝐶𝑁𝑇2 − 𝐵𝐼𝑂𝐿𝐶𝑁𝑇1

Variable:

Change in Self-Assessed Health
Status

Type:

Num (8)

SAS Name:

HEALTHCHG

Format:

BEST

Notes:

Calculated as: 𝐻𝐸𝐴𝐿𝑇𝐻𝐶𝐻𝐺 = 𝐻𝐸𝐴𝐿𝑇𝐻2 − 𝐻𝐸𝐴𝐿𝑇𝐻1
Range: -3 to +3.

Variable:

RUCA Code

Type:

Num (8)

SAS Name:

RUCACOD

Format:

BEST

Notes:

Index describing degree of urbanization. RUCACOD is mapped to ZIP using
tables from the Rural Health Research Center. Variable takes discrete,
nominal values ranging from 1.0 to 10.6.

Variable:

RUCA Category

Type:

Num (8)

SAS Name:

RUCACAT

Format:

RUCACATFMT

Value

Label

1

Urban

3

Small rural

2

Large rural

4

Isolated

Notes:

Groupings of RUCA codes defined by the Rural Health Research Center.
RUCACAT = 1 when RUCACOD = 1.0, 1.1, 2.0, 2.1, 3.0, 4.1, 5.1, 7.1, 8.1, or 10.1.
RUCACAT = 2 when RUCACOD = 4.0, 4.2, 5.0, 5.2, 6.0, or 6.1.
RUCACAT = 3 when RUCACOD = 7.0, 7.2, 7.3, 7.4, 8.0, 8.2, 8.3, 8.4, 9.0, 9.1, or 9.2.
RUCACAT = 4 when RUCACOD = 10.0, 10.2, 10.3, 10.4, 10.5, or 10.6.
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Variable:

Simplified RUCA Category

Type:

Num (8)

SAS Name:

RUCASIMP

Format:

RUCASIMPFMT

Value

Label

1

Urban

2

Rural or Isolated
Notes:

Simplified dichotomization of RUCA Category.
RUCASIMP is 1 when RUCACAT is 1.
RUCASIMP is 2 when RUCACAT is 2, 3, or 4.
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Appendix B – FORWARD Phases
An index of the phases identified in FORWARD data is given in Table B1. Survey periods begin in
January and July of each year. Surveys are typically completed within the 6-month period beginning with
January or July, though a small number of surveys in the dataset were returned slightly later. The review
period is the 6-month period prior to the survey’s release. Survey questions predominantly ask about
patient experience during this time. The phase number refers to the review period, not the period
during which the survey is released.
Table B1
FORWARD Phases
Phase

Review Period

Survey Date

Phase

Review Period

Survey Date

35

January - June 1998

July 1998

55

January - June 2008

July 2008

36

July - December 1998

January 1999

56

July - December 2008

January 2009

37

January - June 1999

July 1999

57

January - June 2009

July 2009

38

July - December 1999

January 2000

58

July - December 2009

January 2010

39

January - June 2000

July 2000

59

January - June 2010

July 2010

40

July - December 2000

January 2001

60

July - December 2010

January 2011

41

January - June 2001

July 2001

61

January - June 2011

July 2011

42

July - December 2001

January 2002

62

July - December 2011

January 2012

43

January - June 2002

July 2002

63

January - June 2012

July 2012

44

July - December 2002

January 2003

64

July - December 2012

January 2013

45

January - June 2003

July 2003

65

January - June 2013

July 2013

46

July - December 2003

January 2004

66

July - December 2013

January 2014

47

January - June 2004

July 2004

67

January - June 2014

July 2014

48

July - December 2004

January 2005

68

July - December 2014

January 2015

49

January - June 2005

July 2005

69

January - June 2015

July 2015

50

July - December 2005

January 2006

70

July - December 2015

January 2016

51

January - June 2006

July 2006

71

January - June 2016

July 2016

52

July - December 2006

January 2007

72

July - December 2016

January 2017

53

January - June 2007

July 2007

73

January - June 2017

July 2017

54

July - December 2007

January 2008

74

July - December 2017

January 2018
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Appendix C – Power Analysis
Power analysis was completed for logistic regression models (Aim 1) and survival models (Aim
2). Both analyses were based on 90% power (β = 0.1), 0.05 significance (α), and a sample size of 5,000
(n). A total sample size of approximately 50,000 was expected; however, the 3 diagnosis groups were
anticipated to vary widely in size, with n = 5,000 anticipated to be the smallest sample size. Therefore,
these power analyses were considered conservative since the sample sizes for some groups were larger.
Preliminary analysis of the data, however, revealed that the SLE group contained only 2,752 subjects.
Power for the SLE models is addressed below.
Logistic Regression Models
For a binary predictor variable in a logistic regression model, Tables C1 and C2 display the lowest
detectable odds ratios given a set of varying parameters: predictor variable distribution (percentage of
sample with X=1), response probability (P0), and correlation between predictor variables (R2). Power was
constant at 90% and significance at 0.05 for all scenarios.
Table C1
Odds Ratios Detectable at 90% Power and α = 0.05
20% of sample with X = 1
R2
P0
0.3
0.5
0.7
0.15 1.431 1.522 1.702
0.30 1.337 1.407 1.549
0.45 1.315 1.383 1.520

40% of sample with X = 1
R2
P0
0.3
0.5
0.7
0.15 1.046 1.060 1.030
0.30 1.036 1.029 1.038
0.45 1.023 1.027 1.035

For a binary predictor variable, assume that 40% of the sample has the characteristic (X=1) and
the probability of dropout for that group is 0.3. If the highest pairwise correlation between the predictor
and the other variables in the model is 0.5, then the lowest detectable odds ratio is 1.036 (Hsieh, Block,
& Larsen 1998).
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Survival Models
Power analysis for the survival model assumed an 80% event rate. This was based on the
information that approximately 50,000 patients have participated in FORWARD surveys throughout its
lifespan, and approximately 10,000 patients participate currently. Table C2 below displays the lowest
detectable hazard ratios given varying predictor variable standard distribution (SD) and correlation (R2).
Power was constant at 90% and significance at 0.05 for all scenarios.
Table C2
Hazard Ratios Detectable at
90% Power and α = 0.05
P0
0.15
0.30
0.45

0.3
1.431
1.337
1.315

R2
0.5
1.522
1.407
1.383

0.7
1.702
1.549
1.520

For a continuous predictor variable assume a standard deviation of 10. If the highest pairwise
correlation between the predictor and the other variables in the model is 0.3, then the lowest
detectable hazard ratio is 1.006 (Hsieh & Lavori 2000; Schoenfeld 1983).
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Appendix D – Duration by Selected Patient Characteristics
Duration patterns were assessed separately for each patient characteristic listed in Table 2.
Visual representations of the findings are given in Figure D1. This initial assessment was informative
only, as each of these predictors was considered for the models regardless of apparent effect on
duration.
Figure D1
Mean Duration by Patient Characteristics for All Groups
Age

Sex

Race

Education Level
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Figure D1
Mean Duration by Patient Characteristics for All Groups
Marital Status

Employment

RUCA Category

Recruitment Type

Note. All characteristics are assessed as of the first survey.

Further analysis was conducted jointly for pairings of these characteristics. The pairwise
assessments were more instructive than the single characteristic, as these plots held the potential to
reveal possible interactions in the multivariable logistic regression models. Differences in the patterns of
vertical bars between clusters might indicate that the effect of one characteristic on duration was
dependent on the level of the paired characteristic. Each possible pairing of characteristics was
assessed, separately for each diagnosis group. Plots that displayed notable variation are shown in
Figures D2, D3, and D4. Such variation was most commonly seen when evaluating characteristics with
many levels, particularly the employment variable. Variation was also more common in plots for the SLE
and other rheumatic disease groups than for the much larger RA group. These observations suggest that
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any apparent variation is likely an effect of small cell counts when the two characteristics are crosstabulated, which result in less regression toward a mean outcome. As such, perceived differences may
not be strong evidence of an interaction. After employing additional methods to select interaction
terms, the only pairing shown below that was used in a full model was that of age and employment in
the other rheumatic diseases group. This interaction was eliminated during selection of the final model.
Figure D2
Mean Duration by Age and Employment for RA Group

Note. Both characteristics are assessed as of the first survey.

Figure D3
Mean Duration by Selected Characteristic Pairs for SLE Group
Age and Employment

Sex and Employment
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Figure D3
Mean Duration by Selected Characteristic Pairs for SLE Group
Employment and Education

Age and Recruitment Type

RUCA Category and Education

Note. All characteristics are assessed as of the first survey.

Figure D4
Mean Duration by Selected Characteristic Pairs for Other Rheumatic Diseases Group
Age and Employment

Sex and Employment
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Figure D4
Mean Duration by Selected Characteristic Pairs for Other Rheumatic Diseases Group
Race and Employment

Race and Recruitment Type

Note. All characteristics are assessed as of the first survey.

Race and RUCA Category
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Appendix E – Logistic Regression Model for RA Group
Results of simple and multiple logistic regressions for patients with RA are presented in the
following tables. Table E1 contains specifications for univariable models that were constructed
separately for each predictor having adequate data and heterogeneity. In cases of categorical variables
with more than 2 levels, a set of indicator terms was used in place of the original variable.
Table E1
Univariable Logistic Regression Results for RA Group
Parameter

b

SE

p

OR [95% CI]

Sex (Male)

0.0674

0.0265

0.011

1.07 [1.02 – 1.13]

Education level (Year)
Race (Black)
Race (Other)
Recruitment (Provider Referral)
Recruitment (Self-Enrolled)
Recruitment (Drug Registries)
Age (Years)

-0.0462
0.4213
0.5070
-0.2917
0.0540
-0.2248
- 0.0072

0.0046
0.0493
0.0441
0.0330
0.0402
0.0331
0.0008

< 0.001
< 0.001
< 0.001
< 0.001
0.179
< 0.001
< 0.001

0.96 [0.95 – 0.96]
1.52 [1.38 – 1.68]
1.66 [1.52 – 1.81]
0.75 [0.70 – 0.80]
1.06 [0.98 – 1.14]
0.80 [0.75 – 0.85]
0.99 [0.99 – 0.99]

Marital Status (Single)
Employment (Housework)
Employment (Paid)
Employment (Retired)
Employment (Student)
Employment (Unemployed)
Income ($30,000 - $59,999)
Income ($60,000 or More)

- 0.2265
- 0.3300
- 0.1920
-0.2572
0.4019
0.2296
- 0.1809
- 0.1932

0.0238
0.0426
0.0337
0.0351
0.1221
0.0677
0.0293
0.0291

< 0.001
< 0.001
< 0.001
< 0.001
0.001
0.001
< 0.001
< 0.001

0.80 [0.76 – 0.84]
0.72 [0.66 – 0.78]
0.83 [0.77 – 0.88]
0.78 [0.72 – 0.83]
1.50 [1.18 – 1.90]
1.26 [1.10 – 1.44]
0.83 [0.79 – 0.88]
0.32 [0.78 – 0.88]

RUCA Category (Urban)
HAQ
PCS

- 0.1250
0.1721
- 0.0115

0.0250
0.0161
0.0011

< 0.001
< 0.001
< 0.001

0.88 [0.84 – 0.93]
1.19 [1.15 – 1.23)
0.99 [0.99 – 0.99]

RDCI
Health Status (Excellent/Good)
Number of Drugs

0.0899
0.4168
- 0.0201

0.0071
0.0228
0.0026

< 0.001
< 0.001
< 0.001

1.09 [1.08 – 1.11]
1.52 [1.45 – 1.59]
0.98 [0.98, 0.99]

Number of DMARDs

- 0.1392

0.0116

< 0.001

0.87 [0.85 – 0.89]

Notes
Reference group: female. Dropped from
consideration due to odds ratio close to 1.
Reference group: White.

Reference group: other recruitment methods.

OR for unit of 10 years was 0.93 (95% CI 0.92, 0.95).
Dropped from consideration due to odds ratio close
to 1.
Reference group: partnered.
Reference group: disabled.

Reference group: income ≤ $30,000. Dropped from
consideration due to lack of evidence for
categorization being meaningful.
Reference group: rural/isolated.

Odds ratio for a change of 10 units was 0.89 [0.87,
0.91]. Dropped from consideration due to
significant correlation with HAQ.
Reference group: fair/poor.
Dropped from consideration due to odds ratio close
to 1.
Dropped from consideration due to highly nonnormal distribution.

Analgesic Use (Yes)
- 0.0051 0.0221
0.816
1.00 [0.95 – 1.04]
Heart Problem (Yes)
0.1843
0.0420 < 0.001 1.20 [1.11 – 1.31]
Note. All variables are assessed as of first survey. RA = rheumatoid arthritis; RUCA = Rural Urban Commuting Area Codes; HAQ
= health assessment questionnaire; PCS = physical component scale; RDCI = rheumatic disease comorbidity index; DMARDs =
disease-modifying anti-rheumatic drugs.
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Results of these univariable models were used to select predictors for the full multivariable
model. For continuous and dichotomous variables, criterium for inclusion was p < 0.05 in the relevant
univariable model. For multi-level categorical variables, the criterium was p < 0.05 for all indicator
variables or, in cases where a subset of indicator terms was significant, p < 0.05 for the Type 3 analysis
of effect. Qualifying continuous predictors were assessed for multicollinearity. HAQ and PCS scores were
found to be moderately correlated (r = - 0.744, p < 0.001). PCS was dropped in favor of HAQ due to more
missing values for PCS (20.8% missing PCS vs. 13.9% missing HAQ). Due to an excess of qualifying
predictors, age, income, and number of DMARDs were excluded from the full model based on subjective
assessment. Selection proceeded by sequential removal of predictors to obtain the final model.
Results of the full and final multivariable models for the RA group are presented in Table E2,
and the series of steps taken to select the final model is given in Table E3. Removal of only one nonsignificant predictor was required to obtain the final model for the RA group.
Table E2
Multivariable Logistic Regression Results for RA Group
Full Model
Parameter
Intercept
Race (Black)
Race (Other)
Marital Status (Single)
Education Level (Years)
Recruitment (Provider Referral)
Recruitment (Self-Enrolled)
Recruitment (Drug Registries)
Employment (Housework)
Employment (Paid Work)
Employment (Retired)
Employment (Student)
Employment (Unemployed)
RUCA Category (Urban)
HAQ Score
RDCI
Health Status (Excellent/Good)
Heart Problem (Yes)

Final Model

b

SE

p

b

SE

p

OR [95% CI]

0.3812
0.3349
0.3827
-0.1405
-0.0529
-0.2630
0.0226
-0.2215
-0.0321
0.1393
0.0164
0.6088
0.3143
-0.1086
-0.2987
0.0545
0.0881
-0.0134

0.1405
0.0625
0.0547
0.0291
0.0059
0.0412
0.0484
0.0419
0.0529
0.0451
0.0445
0.1398
0.0794
0.0315
0.0702
0.0099
0.0563
0.0549

0.007
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
0.640
< 0.001
0.544
0.002
0.713
< 0.001
< 0.001
0.001
< 0.001
< 0.001
0.118
0.807

0.3816
0.3350
0.3828
-0.1404
-0.0529
-0.2632
0.0226
-0.2217
-0.0321
0.1394
0.0162
0.6089
0.3145
-0.1087
-0.2984
0.0537
0.0881
--

0.1405
0.0625
0.0547
0.0291
0.0059
0.0412
0.0484
0.0419
0.0529
0.0451
0.0445
0.1398
0.0794
0.0315
0.0702
0.0093
0.0563
--

0.007
< 0.001
< 0.001
< 0.001 a
< 0.001
< 0.001 a
0.640 a
< 0.001 a
0.544 a
0.002 a
0.716 a
< 0.001 a
< 0.001 a
0.001
< 0.001
< 0.001
0.117 c
--

N/A
1.40 [1.24 - 1.58]
1.47 [1.32 - 1.63]
0.87 [0.82 - 0.92]
0.95 [0.94 - 0.96]
0.77 [0.71 - 0.83]
1.02 [0.93 - 1.12] b
0.80 [0.74 - 0.87]
0.97 [0.87 - 1.07] b
1.15 [1.05 - 1.26]
1.02 [0.93 - 1.11] b
1.84 [1.40 - 2.42]
1.37 [1.17 - 1.60]
0.90 [0.84 - 0.95]
0.74 [0.65 - 0.85)
1.06 [1.04 - 1.07]
1.09 [0.98 - 1.22] b
--
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Table E2
Multivariable Logistic Regression Results for RA Group
Full Model
Parameter

b

SE

Final Model
p

b

SE

p

OR [95% CI]

Infection (Yes)
0.1164 0.0293 < 0.001 0.1165 0.0293 < 0.001
1.12 [1.06 - 1.19]
Infection (Yes) * HAQ Score
0.2029 0.0440 < 0.001 0.2028 0.0440 < 0.001
1.22 [1.12 - 1.34]
Note. Reference categories for categorical variables are given in Table E1. All values are assessed as of the first survey.
RA = rheumatoid arthritis; RUCA = Rural Urban Commuting Area Codes; HAQ = health assessment questionnaire; RDCI
= rheumatic disease comorbidity index.
a Type 3 analysis of effect indicated a significant overall effect for these predictors (recruitment: p < 0.001;
employment: p < 0.001). b Confidence interval is inclusive of 1. Odds ratio may be informative but should not be
considered definitive. c The main effect of health status was retained in the model due to involvement in a significant
interaction.

Table E3
Logistic Regression Model Selection for RA Group
# Description
Action Taken
AIC
1 Full Model
32169.76
2 Final Model
Removed Heart Problem
32167.82
3 Exploratory Model
Removed HAQ * Health Status
32187.11
Note. A chi-square test comparing Models 2 and 3 indicated that the
model containing the interaction term was a significantly better fit than
the reduced model (Χ2 = 19.297, p < 0.001). RA = rheumatoid arthritis;
HAQ = health assessment questionnaire.

Indicator terms for multilevel categorical variables required selection of a single reference
group; however, comparisons among other levels of the predictors are of interest. To this end, odds
ratios comparing selected levels of the race, recruitment, and employment variables are presented in
Table E4. Given greater interest in the groups that are at higher risk of failure, all comparisons are made
in the direction resulting in an odds ratio greater than 1.
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Table E4
Selected Pairwise Odds Ratios for the RA Group
Race
Comparison

Employment
OR [95% CI]

Comparison

OR [95% CI]

Black vs. White

1.40 [1.24, 1.58]

Paid Work vs. Disabled

1.15 [1.05, 1.26]

Other vs. White

1.47 [1.32, 1.63]

Paid Work vs. Retired

1.13 [1.06, 1.21]

Unemployed vs. Paid Work

1.19 [1.03, 1.38]

Retired vs. Disabled

1.02 [0.93, 1.11] a

Unemployed vs. Retired

1.35 [1.16, 1.56]

Other vs. Black

1.05 [0.90,

1.23] a

Recruitment
Comparison

OR [95% CI]

Self-Enrolled vs. Provider Referral

1.33 [1.23, 1.44]

Drug Registries vs. Provider Referral

1.04 [0.98, 1.11] a

Self-Enrolled vs. Drug Registries

1.28 [1.18, 1.39]

Note. RA = rheumatoid arthritis.
a Confidence interval is inclusive of 1. Odds ratio may be informative but should not be considered not definitive.
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Appendix F – Logistic Regression Model for SLE Group
Results of univariable logistic regression models for the SLE group are presented in Table F1.
Refer to Appendix E for more information.

Table F1
Univariable Logistic Regression Results for SLE Group
Parameter

b

SE

p

OR [95% CI]

RA
Sex (Male)
Education Level (Years)
Race (Black)
Race (Other)
Recruitment (Provider Referral)
Recruitment (Self-Enrolled)
Recruitment (Drug Registries)
Age
Marital Status (Single)
Employment (Housework)
Employment (Paid)
Employment (Retired)
Employment (Student)
Employment (Unemployed)
Income ($30,000 - $59,999)
Income ($60,000 or More)

- 0.1648
0.1901
-0.0520
0.1536
0.2056
- 0.9757
0.0717
- 0.3143
- 0.0108
- 0.1817
- 0.2469
- 0.3501
- 0.4738
0.0564
0.0724
- 0.0781
- 0.4036

0.0974
0.1634
0.0180
0.1171
0.1337
0.3886
0.0810
0.1435
0.0029
0.0789
0.1371
0.0982
0.1308
0.2657
0.1870
0.1030
0.0958

0.091
0.245
0.004
0.190
0.124
0.012
0.376
0.029
< 0.001
0.021
0.072
< 0.001
< 0.001
0.832
0.699
0.448
< 0.001

0.85 [0.70 – 1.03]
1.21 [0.88 – 1.67]
0.95 [0.92, 0.98]
1.17 [0.93 – 1.47]
1.23 [0.95 – 1.60]
0.38 [0.18 – 0.81]
1.07 [0.92 – 1.26]
0.73 [0.55 – 0.97]
0.99 [0.99 – 0.99]
0.83 [0.71 – 0.97]
0.78 [0.60 – 1.02]
0.71 [0.58 – 0.85]
0.62 [0.48 – 0.81]
1.06 [0.63 – 1.78]
10.8 [0.75 – 1.56]
0.93 [0.76 – 1.13]
0.67 [0.55 – 0.81]

RUCA Category (Urban)
HAQ
PCS

- 0.0780
0.1459
- 0.0097

0.0898
0.0572
0.0037

0.385
0.011
0.008

0.93 [0.78 – 1.10]
1.16 [1.03 – 1.30]
0.99 [0.98 – 0.99]

Notes

Type 3 analysis of effect indicated a significant
overall effect for the categorical variable (p =
0.005).

Type 3 analysis of effect indicated a significant
overall effect for the categorical variable (p <
0.001).

Type 3 analysis of effect indicated a significant
overall effect for the categorical variable (p <
0.001).

Odds ratio for a change of 10 units was 0.91 [0.85,
0.98].

RDCI
0.0132 0.0205
0.520 1.01 [0.97 – 1.06]
Health Status (Excellent/Good)
0.3162 0.0791 < 0.001 1.37 [1.18 – 1.60]
Number of Drugs
- 0.0277 0.0082 < 0.001 0.97 [0.96 – 0.99]
Number of DMARDs
- 0.1637 0.0497 0.0010 0.85 [0.77 – 0.94]
Analgesic Use (Yes)
0.0137 0.0782
0.861 1.01 [0.87 – 1.18]
Heart Problem (Yes)
0.0220 0.1168
0.851 1.02 [0.81 – 1.29]
Infection (Yes)
0.0216 0.0790
0.785 1.02 [0.88 – 1.19]
Note. All variables are assessed as of first survey. SLE = systemic lupus erythematosus; RUCA = Rural Urban Commuting Area
Codes; HAQ = health assessment questionnaire; PCS = physical component scale; RDCI = rheumatic disease comorbidity index;
DMARDs = disease-modifying anti-rheumatic drugs.

As with the RA group, HAQ and PCS scores were moderately correlated (r = - 0.752, p < 0.001). In
the case of the SLE group, however, missing rates for the two variables were similar (HAQ 14.0%, PCS
13.3%). Given that the correlation coefficient was borderline to the threshold set as warranting action (r
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= 0.8), several exploratory models were considered to assess whether parameter estimate for each
variable was greatly affected by the presence or absence of the collinear predictor. These exploratory
models contained HAQ score, PCS score, all other qualifying predictors and 2 interaction terms that had
been previously identified as potentially relevant. Parameter estimates for these models are given in
Table F2. The parameter estimate for HAQ changed in both magnitude and direction depending on the
presence of PCS, whereas the parameter estimate for PCS remained essentially the same. Further,
although the effect of neither predictor was significant, the p-values for PCS was much lower than those
for HAQ. As a result, PCS score was included in the full multivariable model, and HAQ score was
eliminated.
Table F2
Evaluation of HAQ and PCS Collinearity Effect
HAQ

PCS

Model
b
p
b
p
Model containing both HAQ and PCS - 0.0445 0.685 - 0.0139
0.054
Model containing HAQ only
0.0888 0.383
--Model containing PCS only
--- 0.0089
Note. Models also contained all covariates that appeared in the full model.
HAQ = health assessment questionnaire; PCS = physical component scale.

All remaining variables that met the selection criteria were included in the full model for the SLE
group. Specifications of the full model and the final model are given in Table F3, and the series of steps
taken to obtain the final model is given in Table F4. A significant interaction effect between self-assessed
health status and employment category was removed from the model in the interest of parsimony. The
model containing the interaction term was not a significantly better fit than the reduced model (Χ2 =
8.143, p = 0.149).
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Table F3
Multivariable Logistic Regression Results for SLE Group
Full Model
Parameter

b

SE

Final Model
p

b

SE

P

OR [95% CI]

Intercept
0.3569
0.7247
0.622
0.8655
0.3127 0.006
N/A
Age (Years)
- 0.0119 0.0048
0.013
-0.0122 0.0041 0.003
0.99 [0.98 - 1.00]
Marital Status (Single)
0.0599
0.1739
0.731
----Education Level (Years)
- 0.0219 0.0218
0.315
----Recruitment (Provider Referral)
- 0.2132 0.1519
0.160
-0.2026 0.1306 0.121 a 0.82 [0.63 - 1.05] b
Recruitment (Self-Enrolled)
- 0.3399
0.157
0.031
-0.4250 0.1400 0.002 a 0.65 [0.50 - 0.86]
Recruitment (Drug Registries)
- 0.3713 0.2015
0.065
-0.5069 0.1863 0.007 a 0.60 [0.42 - 0.87]
Employment (Housework)
1.9345
0.6502
0.003
-0.2387 0.1565 0.127 a 0.79 [0.58 - 1.07] b
Employment (Paid work)
0.9331
0.5380
0.083
-0.3542 0.1235 0.004 a 0.70 [0.55 - 0.89]
Employment (Retired)
0.0705
0.6773
0.917
-0.3654 0.1618 0.024 a 0.69 [0.51 - 0.95]
Employment (Student)
- 1.4369
1.208
0.234
-0.3369 0.3019 0.264 a 0.71 [0.40 - 1.29] b
Employment (Unemployed)
0.3926
0.874
0.653
0.0687
0.2001 0.731 a 1.07 [0.72 - 1.59] b
Income ($30,000 - $59,999)
0.2262
0.4124
0.583
-0.0014 0.1104 0.990 a 1.00 [0.80 - 1.24] b
Income ($60,000 or More)
0.3004
0.4774
0.529
-0.2682 0.1074 0.012 a 0.76 [0.62 - 0.94]
Health Status (Excellent/Good)
0.7090
0.2619
0.007
0.2251
0.0931 0.016
1.25 [1.04 - 1.50]
PCS Score
- 0.0094 0.0059
0.114
----RDCI
- 0.0187 0.0299
0.531
----Number of Drugs
- 0.0265 0.0136
0.052
-0.0295 0.0101 0.004
0.97 [0.95 - 0.99]
Number of DMARDs
- 0.0135 0.0708
0.848
----Marital Status (Single) *
- 0.1171 0.2573
0.649
----Income ($30,000 - $59,999)
Marital Status (Single) *
- 0.3179 0.2763
0.250
----Income ($60,000 or More)
Health Status (Excellent/Good) *
- 1.3578 0.3830 < 0.001
----Employment (Housework)
Health Status (Excellent/Good) *
- 0.7417 0.2995
0.013
----Employment (Paid work)
Health Status (Excellent/Good) *
- 0.2174 0.3804
0.568
----Employment (Retired)
Health Status (Excellent/Good) *
1.0879
0.7898
0.168
----Employment (Student)
Health Status (Excellent/Good) *
- 0.1175 0.4908
0.811
----Employment (Unemployed)
Note. Reference categories for categorical variables are given in Table E1. All variables are assessed as of first survey. SLE =
systemic lupus erythematosus. SLE = systemic lupus erythematosus; PCS = physical component scale; RDCI = rheumatic
disease comorbidity index; DMARDs = disease-modifying anti-rheumatic drugs.
a Type 3 analysis of effect indicated a significant overall effect for these categorical variables (Recruitment: p = 0.005;
Employment: p = 0.029; Income: p = 0.015). b Confidence interval is inclusive of 1. Odds ratio may be informative but should
not be considered definitive.
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Table F4
Logistic Regression Model Selection for SLE Group
# Description
Action Taken
AIC
1 Full Model
2516.41
2 Interim Model
Removed DMARDs
2514.42
3 Interim Model
Removed Marital Status * Income
2511.75
4 Interim Model
Removed Marital Status
2530.56
5 Interim Model
Removed Education
2923.49
6 Interim Model
Removed PCS
3172.43
7 Final Model
Removed Health Status * Employment
3180.58
Note. SLE = systemic lupus erythematosus; DMARDs = disease-modifying antirheumatic drugs; PCS = physical component scale.

Table F5
Selected Pairwise Odds Ratios for the SLE Group
Recruitment
Comparison

Employment
OR [95% CI]

Comparison

OR [95% CI]

Provider Referral vs. Self-Enrolled

1.25 [1.03, 1.52]

Disabled vs. Paid Work

1.43 [1.12, 1.82]

Provider Referral vs. Drug Registries

1.36 [0.99, 1.85] a

Paid Work vs. Retired

1.01 [0.74, 1.38] a

Self-Enrolled vs. Drug Registries

1.09 [0.78, 1.50] a

Unemployed vs. Paid Work

1.53 [1.05, 2.23]

Disabled vs. Retired

1.44 [1.05, 1.98]

Unemployed vs. Retired

1.54 [0.98, 2.43] a

Income
Comparison

OR [95% CI]

Less Than $30,000 vs. $30,000 - $59,999

1.00 [0.81, 1.24] a

Less Than $30,000 vs. $60,000 or More

1.34 [1.06, 1.61]

$30,000 - $59,999 vs. $60,000 or More

1.31 [1.06, 1.61]

Note. SLE = systemic lupus erythematosus.
a Confidence interval is inclusive of 1. Odds ratio may be informative but should not be considered not
definitive.
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Appendix G – Logistic Regression Model for Other Rheumatic Diseases Group
Results of logistic regression models for the other rheumatic diseases group are presented in
Tables G1, G2, G3, and G4. Refer to Appendix E for more information. HAQ and PCS scores were
moderately correlated (r = - 0.720, p < 0.001). As with the RA group, PCS was dropped in favor of HAQ
due to more missing values for PCS (16.7% missing PCS vs. 10.4% missing HAQ). Number of drugs, whose
odds ratio was very close to 1, was eliminated due to an excess of qualifying predictors. Model selection
proceeded with the remaining predictors. The final model (Model 7) contained an interaction between
age and employment whose overall effect was significant (p < 0.001) but for which only 1 of the 5 levels
(retired patients) was significant on its own. The case was the same with the main effect of
employment. A reduced model (Model 8) was fit without the interaction term. Model 8 was a
significantly poorer fit (p = 0.004) but had only a slightly higher AIC (13548.30 vs. 13531.13). No level of
the main effect of unemployment was significant in Model 8 (Type 3 p = 0.099), so model selection
continued with a removal of this main effect (Model 9). However, the AIC increased considerably to
13816.067. Ultimately Model 7, which included both the employment main effect and the employmentage interaction, was selected as final.
Table G1
Univariable Logistic Regression Results for Other Rheumatic Diseases Group
Parameter
Sex (Male)
Education Level (Years)
Race (Black)
Race (Other)
Recruitment
(Provider Referral)
Recruitment (Self-Enrolled)
Recruitment (Drug Registries)
Age (Years)
Marital Status (Single)
Employment (Housework)
Employment (Paid)
Employment (Retired)
Employment (Student)

b

SE

p

OR [95% CI]

0.2114
-0.0516
0.3253
0.2880
-0.0175

0.0434
0.0075
0.0884
0.0870
0.0683

<.001
<.001
<.001
0.001
0.798

1.24 [1.13 - 1.35]
0.95 [0.94 - 0.96]
1.38 [1.16 - 1.65]
1.33 [1.12 - 1.58]
0.98 [0.86 - 1.12]

0.0471
0.1666
-0.0143
-0.1950
-0.4124
-0.1901
-0.3880
0.5310

0.0728
0.0856
0.0012
0.0345
0.0636
0.0509
0.0526
0.1658

0.517
0.052
<.001
<.001
<.001
<.001
<.001
0.001

1.05 [0.91 - 1.21]
1.18 [1.00 - 1.40]
0.99 [0.98 - 0.99]
0.82 [0.77 - 0.88]
0.66 [0.58 - 0.75]
0.83 [0.75 - 0.91]
0.68 [0.61 - 0.75]
1.70 [1.23 - 2.35]

Notes
Reference group: female.
OR for unit of 4 years was 0.81 [95% CI 0.77, 0.86].
Reference group: White.

Reference group: other recruitment methods.

OR for unit of 10 years was 0.87 [95% CI 0.85, 0.89].
Reference group: partnered.
Reference group: disabled.
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Table G1
Univariable Logistic Regression Results for Other Rheumatic Diseases Group
Parameter

b

SE

p

OR [95% CI]

Employment (Unemployed)
Income ($30,000 - $59,999)
Income ($60,000 or More)
RUCA Category (Urban)
HAQ
PCS

0.1333
-0.1678
-0.1464
0.0010
0.1014
-0.0040

0.0901
0.0436
0.0424
0.0371
0.0256
0.0017

0.139
<.001
0.001
0.978
<.001
0.016

1.14 [0.96 - 1.36]
0.85 [0.78 - 0.92]
0.86 [0.79 - 0.94]
1.00 [0.93 - 1.08]
1.11 [1.05 - 1.16]
1.00 [0.99 - 1.00]

MCS

-0.0184

0.0015

<.001

0.98 [0.98 - 0.98]

RDCI
Health Status (Excellent/Good)
Number of Drugs

0.0464
0.3177
-0.0134

0.0102
0.0335
0.00382

<.001
<.001
<.001

1.05 [1.03 - 1.07]
1.37 [1.29 - 1.47]
0.99 [0.98 - 0.99]

Notes
Reference group: income ≤ $30,000.

Reference group: rural/isolated.

Odds ratio for a change of 10 units was 0.96 [0.93,
0.99]. Dropped from consideration due to significant
correlation with HAQ.
Odds ratio for a change of 10 units was 0.83 [0.81,
0.86].
Reference group: fair/poor.
Dropped from consideration due to odds ratio close
to 1.

Number of DMARDs
0.1548
0.0295
<.001
1.17 [1.10 - 1.24]
Analgesic Use (Yes)
-0.0764
0.0332
0.021
0.93 [0.87 - 0.99]
Heart Problem (Yes)
0.0470
0.0556
0.398
1.05 [0.94 - 1.17]
Infection (Yes)
0.2447
0.0342
<.001
1.28 [1.19 - 1.37]
Note. All variables are assessed as of first survey. RUCA = Rural Urban Commuting Area Codes; HAQ = health assessment
questionnaire; PCS = physical component scale; MCS = mental component scale; RDCI = rheumatic disease comorbidity index;
DMARDs = disease-modifying anti-rheumatic drugs.

Table G2
Multivariable Logistic Regression Results for Other Rheumatic Diseases Group
Full Model
Parameter
Intercept
Sex (Male)
Age (Years)
Race (Black)
Race (Other)
Marital Status (Single)
Education Level (Years)
Recruitment (Provider Referral)
Recruitment (Self-Enrolled)
Recruitment (Drug Registries)
Employment (Housework)
Employment (Paid Work)
Employment (Retired)
Employment (Student)
Employment (Unemployed)
Income ($30,000 - $59,999)
Income ($60,000 or More)
HAQ
MCS
RDCI

b
1.8173
0.2087
- 0.0150
0.3109
0.2319
- 0.1364
- 0.0563
0.1600
0.0401
0.3582
0.1581
0.0348
- 1.6271
0.7004
0.4863
0.0402
0.1047
- 0.0545
- 0.0125
0.0133

SE

Final Model
p

b

SE

p

0.3895 < 0.001 1.8741 0.3457 < 0.001
0.0619 0.001
0.2401 0.0574 < 0.001
0.0060 0.012 - 0.0166 0.00565
0.003
0.1117 0.005
0.2702 0.1069
0.012 b
0.1075 0.031
0.2117 0.1024
0.039 b
0.0528 0.010 - 0.0942 0.0459
0.040
0.0103 < 0.001 - 0.0525 0.0092 < 0.001
0.0892 0.073
0.1232 0.0827
0.136 b
0.0944 0.671 - 0.0169 0.0884
0.849 b
0.1093 0.001
0.2987 0.1029
0.003 b
0.4281 0.712 - 0.2802 0.4041
0.488 b
0.3589 0.923 - 0.0250 0.3422
0.942 b
0.4897 0.001 - 1.8007 0.4601 < 0.001 b
0.6200 0.259
0.6493 0.5796
0.263 b
0.5737 0.397
0.2621 0.5433
0.630 b
0.0594 0.499
---0.0665 0.115
---0.0436 0.212
---0.0021 < 0.001 - 0.0114 0.00184 < 0.001
0.0152 0.382
----

OR [95% CI]
6.51 [3.31, 12.83]
1.27 [1.14, 1.42]
0.98 [0.97, 0.99] a
1.31 [1.06, 1.62]
1.24 [1.01, 1.51]
0.91 [0.83, 1.00]
0.95 [0.93, 0.97]
1.13 [0.96, 1.33] c
0.98 [0.83, 1.17] c
1.35 [1.10, 1.65]
0.76 [0.34, 1.67] a, c
0.98 [0.50, 1.91] a, c
0.17 [0.07, 0.41] a
1.91 [0.61, 5.96] a, c
1.30 [0.45, 3.77] a, c
---0.99 [0.99, 0.99]
--
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Table G2
Multivariable Logistic Regression Results for Other Rheumatic Diseases Group
Full Model
Parameter

b

SE

Final Model
p

b

SE

p

OR [95% CI]

Number of DMARDs
0.0501 0.0411 0.223
----Health Status (Excellent/Good)
0.0504 0.0536 0.348
----Analgesic Use (Yes)
- 0.0652 0.0456 0.153
----Infection (Yes)
0.1592 0.0459 0.001
0.1744 0.0432 < 0.001
1.19 [1.09, 1.30]
Age * Employment (Housework)
- 0.0040 0.0076 0.600
0.0039 0.0071
0.587 b
1.00 [0.99, 1.02] a
Age * Employment (Paid Work)
- 0.0017 0.0067 0.795 - 0.0003 0.00642 0.959 b
1.00 [0.99, 1.01] a
Age * Employment (Retired)
0.0248 0.0079 0.002
0.0273 0.0074 < 0.001 b 1.03 [1.01, 1.04] a
Age * Employment (Student)
- 0.0149 0.0160 0.351 - 0.0136 0.0149
0.361 b
0.99 [0.96, 1.02] a
b
Age * Employment (Unemployed)
- 0.0069 0.0110 0.531 - 0.0018 0.0103
0.859
1.00 [0.98, 1.02] a
Note. Reference categories for categorical variables are given in Table F1. All values are assessed as of the first
survey. HAQ = health assessment questionnaire; MCS = mental component score; RDCI = rheumatic disease
comorbidity index.
a Because the model contains an interaction between age and employment category, the odds ratios given for each
main effect and for the interaction terms are valid only in certain cases. See Table 3 for odds ratios interpreted at
clinically applicable levels. b Type 3 analysis of effect indicated a significant overall effect for the predictor (race: p =
0.006; recruitment: p < 0.001; employment: p < 0.001; age*employment: p < 0.001). c Confidence interval is
inclusive of 1. Odds ratio may be informative but should not be considered definitive.

Table G3
Logistic Regression Model Selection for Other Rheumatic
Diseases Group
# Description
Action Taken
AIC
1 Full Model
12223.38
2 Interim Model
Removed RDCI
12225.74
3 Interim Model
Removed Income
13116.17
4 Interim Model
Removed DMARDs
13116.05
5 Interim Model
Removed HAQ
13191.88
6 Interim Model
Removed Health Status
13529.98
7 Final Model
Removed Analgesic Use
13531.13
8 Exploratory model
Removed Employment * Age
13548.30
13816.07
9 Exploratory model
Removed Employment
Note. RA = rheumatoid arthritis; SLE = systemic lupus erythematosus;
RUCA = Rural Urban Commuting Area Codes; HAQ = health assessment
questionnaire; PCS = physical component scale; MCS = mental
component scale; RDCI = rheumatic disease comorbidity index.

Table G4
Selected Pairwise Odds Ratios for Recruitment
Type in the Other Rheumatic Diseases Group
Comparison

OR [95% CI]

Provider Referral vs. Self-Enrolled

1.15 [1.04, 1.27]

Drug Registries vs. Provider Referral

1.19 [1.03, 1.37]

Drug Registries vs. Self-Enrolled

1.37 [1.18, 1.60]
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Appendix H – Survival Model for RA Group
Kaplan-Meier survival plots were constructed for each predictor being evaluated for inclusion in
the RA group survival model. These included all variables with adequate heterogeneity and a sufficiently
low level of missing values. Observations from each patient’s first and last surveys were considered,
along with difference between the two values if feasible. The Kaplan-Meier plots contained separate
curves for each level of the predictor under assessment, with continuous variables categorized into
similarly sized groups. Using the LIFETEST procedure in SAS, a chi-square test was performed to identify
significant inequality between strata. Predictors with p < 0.05 in this test were considered viable
candidates for the model. In cases where multiple observations (first, last, or change) for the same
variable qualified, only one was permitted. Preference was given to the last survey observation or
longitudinal change, and ultimately no first-survey observations were selected for any group. The
remaining set of predictors was further reduced by subjective evaluation of differences in the KaplanMeier plots and by degree of clinical interest, and from these the full multivariable model was
constructed. Figure H1 contains the Kaplan-Meier plots for all variables appearing in the full model.
Figure H1
Kaplan-Meier Survival Plots by Selected Predictors for RA Group
Sex

Age
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Figure H1
Kaplan-Meier Survival Plots by Selected Predictors for RA Group
Race

Recruitment

Education Level

Marital Status

Employment

Health Status
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Figure H1
Kaplan-Meier Survival Plots by Selected Predictors for RA Group
Change in RDCI

Number of Drugs a

Note. RA = rheumatoid arthritis; RDCI = rheumatic disease comorbidity index.

The proportional hazards assumption for the survival models was evaluated using Schoenfeld
residuals and observed vs. expected plots. A summary of findings is presented in Table H1. A p-value of
less than 0.05 in the Schoenfeld residuals test indicated that residuals for that variable were significantly
correlated with duration. This was suggestive of failure to meet the proportional hazards assumption. In
the observed vs. expected plots, shown in Figure H2, the actual survival probability curve for each level
of the variable under evaluation is compared to a predicted curve. As with the Kaplan-Meier plots,
continuous variables have been categorized. Blatant inconsistency between corresponding observed
and expected curves is suggestive of failure to meet the proportional hazards assumption.
In the case of the recruitment variable, both the Schoenfeld residuals test and the observed vs.
expected plot indicated that failure to meet the proportional hazards assumption, and as a result the
model was stratified on this variable. The Schoenfeld test also suggested that age, marital status, and
health status violated the assumption (p < 0.001 in each case); however, the observed vs. expected plots
for each predictor were highly consistent. Conversely, the observed vs. expected plots for employment
indicated a possible violation, but a p-value of 0.688 in the Schoenfeld test suggested otherwise. Each of
these variables was retained as a predictor in the full model without stratification.
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Table H1
Evaluation of Proportional Hazards Assumption for RA Group
Schoenfeld
Residuals (p)

Observed vs.
Expected Plots

0.097
0.277

Highly Consistent
Highly Consistent

Race
Recruitment
Age

0.216
0.012 a
< 0.001 a

Highly Consistent
Not Consistent a
Highly Consistent

Marital Status
Employment
Health Status
Number of Drugs

< 0.001 a
0.688
< 0.001 a
0.742

Highly Consistent
Not Consistent a
Highly Consistent
Acceptable

0.375

Highly Consistent

Parameter
Sex
Education Level

Change in RDCI

Notes
Education level was categorized as ≤ 12
years, 13 – 16 years, and ≥ 17 years.
Selected for stratification.
Age was categorized as < 50 years, 51 –
60 years, 61 – 70 years, and ≥ 70 years.

Number of drugs was categorized as ≤ 4,
5 – 7, and ≥ 8.
Change in RDCI was categorized as
decreased, remained the same, and
increased.

Note. All dynamic variables are assessed as of the last survey. RA = rheumatoid arthritis; RDCI =
rheumatic disease comorbidity index.
a Test suggests failure to meet the proportional hazards assumption.

Figure H2
Observed vs. Expected Plots by Selected Predictors for RA Group
Sex

Age
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Figure H2
Observed vs. Expected Plots by Selected Predictors for RA Group
Race

Recruitment

Education Level

Marital Status

Employment

Health Status
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Figure H2
Observed vs. Expected Plots by Selected Predictors for RA Group
Change in RDCI

Number of Drugs

Note. RA = rheumatoid arthritis; RDCI = rheumatic disease comorbidity index.

The full model, stratified on recruitment, was considered both without interaction (Model 1)
and with interaction (Model 2). Full specification of Model 1 is given in Table H2, and selected
information about Model 2 is given in Table H3. Model 2 performed slightly better than Model 1 (total
AIC 267,662.10 vs. 267,678.06), but the difference was not statistically significant (p = 0.316). Model 1
contained only a single non-significant term (the indicator variable for other race); however, Type 3
analysis of effect indicated that the overall effect of the predictor was significant (p = 0.001), and the
predictor was retained. Model 1 was selected as the final model.
Table H2
Survival Model for RA Group Stratified on Recruitment Without Interaction
Parameter

b

SE

p

Hazard Ratio [95% CI]

Sex (Male)
Age (Years)
Race (Black)
Race (Other)

0.1482
- 0.0264
0.1331
0.0268

0.0198
0.0007
0.0369
0.0326

< 0.001
< 0.001
< 0.001
0.411

1.16 [1.12, 1.21]
0.97 [0.97, 0.98]
1.14 [1.06, 1.23]
1.03 [0.96, 1.09]

Marital Status (Single)
Education Level (Years)
Employment (Housework)
Employment (Paid work)
Employment (Retired)
Employment (Student)
Employment (Unemployed)
Change in RDCI

- 0.0498
- 0.0460
0.1986
0.1150
0.0971
0.2208
0.2350
- 0.0436

0.0164
0.0033
0.0295
0.0252
0.0250
0.1051
0.0483
0.0048

0.002
< 0.001
< 0.001
< 0.001
< 0.001
0.036
< 0.001
< 0.001

0.95 [0.92, 0.98]
0.96 [0.95, 0.96]
1.22 [1.15, 1.29]
1.12 [1.07, 1.18]
1.10 [1.05, 1.16]
1.25 [1.01, 1.53]
1.26 [1.15, 1.39]
0.96 [0.95, 0.97]

Notes
Reference group: Female.

Reference group: White. Odds ratio for
other race vs. White was inconclusive due
to the insignificant p-value for the
parameter estimate.
Reference group: Partnered.

Reference group: Disabled.
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Table H2
Survival Model for RA Group Stratified on Recruitment Without Interaction
Parameter

b

SE

p

Hazard Ratio [95% CI]

Health Status (Excellent/Good)
0.0484
0.0161
0.003
1.05 [1.02, 1.08]
Number of Drugs
- 0.0144
0.0020
< 0.001
0.99 [0.98, 0.99]
Note. RA = rheumatoid arthritis; RDCI = rheumatic disease comorbidity index.

Notes
Reference group: Fair/Poor.

Table H3
Survival Model for RA Group Stratified on Recruitment With Interaction
Provider Referral
Parameter

b

p

Self-Enrolled
b

p

Drug Registries
b

Sex
0.1721 < 0.001
0.2588 < 0.001 0.0942
Education Level (Years)
- 0.0535 < 0.001
-0.0152
0.086 - 0.0409
Race (Black)
0.1174
0.045
0.0764
0.543 0.1859
Race (Other)
- 0.0042
0.943
0.0507
0.533 0.0249
Age (Years)
- 0.0278 < 0.001
- 0.0239 < 0.001 - 0.0267
Marital Status (Single)
- 0.0631
0.015
- 0.0852
0.068 - 0.0315
Employment (Housework)
0.2198 < 0.001
0.3901 < 0.001 0.1753
Employment (Paid work)
0.0644
0.122
0.1807
0.006 0.1669
Employment (Retired)
0.1270
0.002
0.1510
0.045 0.0610
Employment (Student)
0.1900
0.363
0.4110
0.039 0.2637
Employment (Unemployed)
0.0733
0.361
0.4670 < 0.001 0.3057
Change in RDCI
- 0.0575 < 0.001 0.000024
0.999 - 0.0527
Health Status
0.0508
0.042
0.0948
0.045 0.0695
(Excellent/Good)
Number of Drugs
- 0.0203 < 0.001
- 0.0148
0.007 - 0.0138
Note. RA = rheumatoid arthritis; RDCI = rheumatic disease comorbidity index.

p

Other
b

p

0.006
< 0.001
0.002
0.659
< 0.001
0.267
< 0.001
< 0.001
0.141
0.159
< 0.001
< 0.001
0.013

0.0916
0.082
- 0.0644 < 0.001
0.0192
0.859
0.0560
0.459
- 0.0243 < 0.001
- 0.0326
0.461
0.0280
0.735
0.0942
0.168
0.0358
0.594
- 0.0435
0.876
0.2738
0.034
- 0.0251
0.053
- 0.0302
0.490

< 0.001

- 0.0006

0.908

As with the logistic regression, comparisons among various levels of the employment variable
were of interest. This variable was highly significant, and meaningful odds ratios were discernable in
several pairings of levels. Selected comparisons are presented in Table H4, all in the direction resulting
in an odds ratio greater than 1.
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Table H4
Selected Pairwise Hazard Ratios for Employment in the RA Group
Comparison

OR [95% CI]

Comparison

OR [95% CI]

Paid Work vs. Retired

1.02 [0.97, 1.07] a

Retired vs. Disabled

1.10 [1.05, 1.16]

Paid Work vs. Disabled

1.12 [1.07, 1.18]

Housework vs. Disabled

1.22 [1.15, 1.29]

Housework vs. Paid Work

1.09 [1.03, 1.15]

Unemployed vs. Disabled

1.26 [1.15, 1.39]

Unemployed vs. Paid Work

1.13 [1.03, 1.24]

Housework vs. Retired

1.11 [1.05, 1.16]

Note. RA = rheumatoid arthritis.
a Confidence interval is inclusive of 1. Odds ratio may be informative but should not be considered
definitive.
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Appendix I – Survival Model for SLE Group
Kaplan-Meier plots for the SLE group are presented in Figure I1. Refer to Appendix H for more
information. Plots are shown for all variables included in the full survival model. Dynamic variables are
assessed as of the last survey.
Figure I1
Kaplan-Meier Survival Plots by Selected Predictors for SLE Group
Age

Race

Education Level

Marital Status

Employment

Health Status
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Figure I1
Kaplan-Meier Survival Plots by Selected Predictors for SLE Group
Infection

Number of Drugs

Change in RDCI

Note. SLE = systemic lupus erythematosus; RDCI = rheumatic disease comorbidity index.

Summarized findings for the proportional hazards assumption are given in Table I1, followed by
observed vs. expected plots in Figure I2. These processes are described in Appendix H. The Schoenfeld
residuals test suggested that marital status violated the assumption (p = 0.001); however, the observed
vs. expected plots were highly consistent. The opposite occurred with the employment variable
(Schoenfeld p = 0.296). Each of these variables was retained as a predictor in the model, and no
variables were removed for stratification.
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Table I1
Evaluation of Proportional Hazards Assumption for SLE Group
Schoenfeld
Residuals (p)

Observed vs.
Expected Plots

Age

0.845

Highly Consistent

Race
Education Level

0.472
0.170

Highly Consistent
Acceptable

Marital Status
Employment
Infection
Number of Drugs
Change in HAQ II Score
Change in RDCI

0.001 a
0.296
0.609
0.188
0.840
0.473

Highly Consistent
Not Consistent a
Highly Consistent
Acceptable
Acceptable
Acceptable

Parameter

Notes
Categorized as < 50 years, 51 – 60 years,
61 – 70 years, and ≥ 70 years.
Categorized as ≤ 12 years, 13 – 16 years,
and ≥ 17 years.

Categorized as ≤ 4, 5 – 7, and > 7.
Categorized as < - 0.1, - 0.1 – 0.1, > 0.1.
Categorized as decreased, remained the
same, and increased.

Note. All variables are assessed as of the last survey. SLE = systemic lupus erythematosus; HAQ =
health assessment questionnaire; RDCI = rheumatic disease comorbidity index.
a Test suggests failure to meet the proportional hazards assumption.

Figure I2
Observed vs. Expected Plots by Selected Predictors for SLE Group
Age

Race

Education Level

Marital Status
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Figure I2
Observed vs. Expected Plots by Selected Predictors for SLE Group
Employment

Infection

Number of Drugs

Change in HAQ II Score

Change in RDCI

Note. SLE = systemic lupus erythematosus; HAQ = health assessment questionnaire; RDCI = rheumatic disease comorbidity
index.
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The full model (Model 1) contained several predictors whose effects were not significant. These
were removed sequentially to arrive at the final model (Model 6). Specification of both Model 1 and
Model 6 is presented in Table I2, and the series of iterations is listed in Table I3.
Table I2
Survival Models for SLE Group
Full Model
Parameter

b

SE

Final Model
p

b

SE

p

OR [95% CI]

Age (Years)
-0.0246 0.0027 < 0.001 -0.0240 0.0021 < 0.001
0.98 [0.97, 0.98]
Race (Black)
-0.0826 0.0837 0.324
----Race (Other)
-0.0917 0.0932 0.325
----Marital Status (Single)
-0.0941 0.0598 0.116
----Education Level (Years)
-0.0468 0.0109 < 0.001 -0.0421 0.0103 < 0.001
0.96 [0.94, 0.98]
Employment (Housework)
-0.0097 0.1046 0.927
----Employment (Paid work)
-0.0460 0.0756 0.543
----Employment (Retired)
-0.0324 0.0950 0.733
----Employment (Student)
-0.1010 0.2290 0.659
----Employment (Unemployed)
0.1922 0.1468 0.190
----Infection (Yes)
0.1963 0.0564 0.001 0.1845 0.0534
0.001
1.20 [1.08, 1.34]
Number of Drugs
-0.0054 0.0063 0.391
----Change in HAQ II Score
-0.1708 0.0547 0.002 -0.1644 0.0504
0.001
0.85 [0.77, 0.94]
Change in RDCI
0.0070 0.0150 0.643
----Note. All dynamic variables are assessed as of the last survey. SLE = systemic lupus erythematosus; HAQ =
health assessment questionnaire; RDCI = rheumatic disease comorbidity index.

Table I3
Survival Model Selection for SLE Group
# Description
Action Taken
AIC
1 Full Model
16360.867
2 Interim Model
Removed Employment
16353.731
3 Interim Model
Removed Change in RDCI
16351.912
4 Interim Model
Removed Number of Drugs
16350.524
5 Interim Model
Removed Race
16348.171
6 Final Model
Removed Marital Status
17903.622
Note. SLE = systemic lupus erythematosus; RDCI = rheumatic disease
comorbidity index.
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Appendix J – Survival Model for Other Rheumatic Diseases Group
Kaplan-Meier plots for the other rheumatic diseases group are presented in Figure J1. Refer to
Appendix H for more information. Plots are shown for all variables included in the full survival model. All
dynamic variables are assessed as of the last survey.
Figure J1
Kaplan-Meier Survival Plots by Selected Predictors for Other Rheumatic Diseases Group
Sex

Age

Race

Education Level

Marital Status

Employment
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Figure J1
Kaplan-Meier Survival Plots by Selected Predictors for Other Rheumatic Diseases Group
Infection

Number of Drugs

Change in RDCI

Note. RDCI = rheumatic disease comorbidity index.

Findings for evaluation of the proportional hazards assumption are given in Table J1, and
observed vs. expected plots are shown in Figure J2. These processes are described in Appendix H. The
Schoenfeld residuals test suggested that age and marital status violated the assumption (p < 0.001 for
each); however, the observed vs. expected plots for each predictor were highly consistent. Both
variables were retained in the model without stratification. Conversely, the observed vs. expected plots
for recruitment and employment indicated a possible violation, but the Schoenfeld residuals test
suggested otherwise (recruitment p = 0.237; employment p = 0.332). The inconsistencies in the
observed vs. expected plots were highly egregious in both cases, and as a result the model was stratified
on both variables.
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Table J1
Evaluation of Proportional Hazards Assumption for Other Rheumatic Diseases Group
Schoenfeld
Residuals (p)

Observed vs.
Expected Plots

0.125
< 0.001 a

Highly Consistent
Highly Consistent

Race
Education Level

0.238
0.679

Acceptable
Highly Consistent

Recruitment
Marital Status
Employment
Infection
Number of Drugs
Change in RDCI

0.237
< 0.001 a
0.332
0.845
0.112
0.077

Not Consistent b
Highly Consistent
Not Consistent b
Highly Consistent
Highly Consistent
Highly Consistent

Parameter
Sex
Age

Notes
Categorized as < 50 years, 51 – 60 years, 61
– 70 years, and ≥ 70 years.
Categorized as ≤ 12 years, 13 – 16 years,
and ≥ 17 years.
Selected for stratification.

Selected for stratification.

Categorized as ≤ 4, 5 – 7, and ≥ 8.
Categorized as decreased, remained the
same, and increased.

Note. All dynamic variables are assessed as of the last survey. RDCI = rheumatic disease comorbidity
index.
a Test suggests failure to meet the proportional hazards assumption.

Figure J2
Observed vs. Expected Plots by Selected Predictors for SLE Group
Sex

Age

Race

Education Level
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Figure J2
Observed vs. Expected Plots by Selected Predictors for SLE Group
Recruitment

Marital Status

Employment

Infection

Number of Drugs

Change in RDCI

Note: SLE = systemic lupus erythematosus; RDCI = rheumatic disease comorbidity index.

The full model, stratified on recruitment and employment, was considered both without
interaction (Model 1) and with interaction (Model 2). The interaction model, being stratified on one
variable with 4 levels and another with 6 levels, contained 24 sets of parameters. Model 1 performed
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better as assessed by AIC (p < 0.001). Selection proceeded with sequential removal of non-significant
predictors from Model 1 to arrive at the final model (Model 5). Specification of both Model 1 and Model
5 is presented in Table J2, and the series of iterations is listed in Table J3. Details of Model 2 are not
provided in the interest of brevity.
Table J2
Survival Model for Other Rheumatic Diseases Group Stratified
on Recruitment and Employment Without Interaction
Full Model
Parameter
Sex (Male)
Age (Years)
Race (Black)
Race (Other)
Education Level (Years)
Marital Status (Single)
Infection (Yes)
Number of Drugs
Change in RDCI

b
0.1092
-0.0272
0.0273
-0.0700
-0.0200
0.0320
0.0264
-0.0130
-0.0138

SE

Final Model
p

b

0.0333 0.001 0.1071
0.0012 < 0.001 -0.0265
0.0627 0.663
-0.0611 0.251
-0.0051 < 0.001 -0.0213
0.0250 0.201
-0.0249 0.289
-0.0031 < 0.001 -0.0150
0.0072 0.057 -0.0142

SE

p

OR [95% CI]

0.0317
0.0011
--0.0050
--0.0029
0.0070

0.001
< 0.001
--< 0.001
--< 0.001
0.042

1.11 [1.05, 1.18]
0.97 [0.97, 0.98]
--0.98 [0.97, 0.99]
--0.99 [0.98, 0.99]
0.99 [0.97, 1.00]

Note. All dynamic variables are assessed as of the last survey. RDCI = rheumatic disease comorbidity index.

Table J3
Survival Model Selection for Other Rheumatic Diseases Group
# Description
Action Taken
AIC
1 Full Model Without Interaction
82798.90
2 Full Model With Interaction
86120.56 a
3 Interim No-Interaction Model
Removed Race
83359.57
4 Interim No-Interaction Model
Removed Infection
86621.55
6 Final No-Interaction Model
Removed Marital Status
89482.04
a Sum of AIC values for the 24 models that resulted from stratification on
recruitment and employment with interaction.

